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INTRODUCTION 
The basis of evolutionary processes resides 
in the dynamic nature of genetic material: novel 
DNA sequences are continually being produced by 
mutation and recombination. Through the 
stabilization and transmission of these genetic 
products, evolutionary directions are 
established. Vertical transmission, the 
transfer of genes from parents to offspring, is 
most generally thought to determine these 
directions. However, it is becoming 
increasingly apparent that another form of 
transmission, horizontal transfer, contributes 
greatly to evolutionary processes in a wide 
variety of organisms. 
Horizontal gene transfer refers to the 
mobilization and stabilization of genetic 
information from one organism to another. Such 
exchange is a well-established phenomenon in the 
prokaryotic kingdom. Among bacteria, 
genetically plastic transmissible elements are 
mobilized into host organisms, where 
modifications and further radial transfer can 
occur. Mobilization primarily involves 
extrachromosomal elements, many of which encode 
systems for their own transfer. (Emphasis 
added.) (From Bacterial Plasmids and Gene Flux 
( 2) • ) 
This dissertation project has sought to elucidate 
the mechanism of horizontal gene transfer of pLV22a, a 4.2 
kb plasmid isolated from Bacteroides fragilis strain LV22. 
The project is comprised of 5 main areas of investigation. 
In the first part of the project, pLV22a was captured by 
the E. coli-Bacteroides shuttle plasmid pGAT400•BglII in a 
series of experiments designed to investigate multiple 
transfer factors native to strain LV22. Fusion of these 2 
2 
plasmids resulted in a conjugatively transferable 
phenotype (i.e., transferable by a conjugation-type 
mechanism). The second line of investigation demonstrated 
that: (g) pLV22a can transfer independently in B. 
fragilis; (b) pLV22a can transfer in Escherichia coli, 
when co-resident with the broad-host-range conjugal (i.e., 
self-transferable) IncPB plasmid R751. 
The third line of investigation sought to define the 
region required for pLV22a transfer in E. coli through the 
use of TnlOOO transposon mutagenesis. A 1.5 kb region was 
identified, and its nucleotide sequence determined. 
The fourth area of investigation identified, using 
computer analysis, five open reading frames of greater 
than 10 kDa; 3 in the •top' strand, and 2 in the 'bottom' 
strand. Complementation analysis was then applied to 
determine which of the 3 top-strand open reading frames 
were required for transfer in E.coli. All 3 open reading 
frames were found to be independently expressed and 
necessary for transfer. 
The fifth line of research utilized sequence and 
complementation analyses to localize the cis-acting pLV22a 
origin of transfer (oriT) to a region within the 1.5 kb 
transfer region. (The oriT is the point at which one 
strand of DNA is specifically nicked in preparation for 
transfer.) Using the polymerase chain reaction and 
complementation analysis, the oriT region was cloned, and 
subsequently found to confer transferability to a 
transfer-deficient E. coli vector. 
3 
CHAPTER 2 
LITERATURE REVIEW 
Physical Characteristics of Members of the Genus 
Bacteroides 
Bacteroides are obligate anaerobic gram negative rod 
bacteria (98). Bacteroides require anaerobic conditions 
for growth, but are also highly aerotolerant, and can 
survive prolonged exposure to oxygen. They are found in 
high concentrations in the colon of both humans and 
animals. Members of the genus include B. fragilis, 
Bacteroides caccae, Bacteroides distasonis, Bacteroides 
eggerthii, Bacteroides merdae, Bacteroides ovatus, 
Bacteroides stercoris, Bacteroides thetaiotaomicron, 
Bacteroides uniformis and Bacteroides vulgatus (97). 
Bacteroides are highly saccharolytic organisms. In 
the gut, most mono- and disaccharides are efficiently 
absorbed in the small intestine, and do not reach the 
colon, where Bacteroides are found (85). Nevertheless, 
these organisms are able to flourish by hydrolyzing a 
variety of complex polysaccharides from both host-ingested 
plant material and host secretions (87). Some of the 
enzymes involved in polysaccharide degradation include 
4 
neuraminidase, a-glucosidase, B-glucosidase, a-
fucosidase, a-N-acetylgalactosaminidase, B-N-
acetylglucosaminidase, a-galactosidase, B-galactosidase, 
chondroitin lyase I, and chondroitin lyase II 
(6,33,38,52). The majority of these enzymes have been 
found to be associated with the outer membrane and 
periplasm, while others are cytosolic in nature. In the 
laboratory, most Bacteroides grow readily on a simple 
defined medium which consists of a fermentable 
carbohydrate, a source of nitrogen such as ammonium 
sulfate, vitamin B12 , heroin, inorganic ions and cysteine 
(as a reductant). Growth rates are about 0.33-1 
generation per hour (85). The pathways used by 
Bacteroides in the metabolism of absorbed carbohydrates 
have not been fully defined, but include Embden-Meyerhof 
glucose fermentation, (53), a glucose--> succinate 
metabolic pathway (98), and possibly a pentose phosphate-
hexose monophosphate shunt pathway (99). 
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Bacteroides cannot use amino acids or proteins as the 
sole source of carbon or energy, nor do they require amino 
acids or peptides when grown on carbohydrates (85). 
Nevertheless, several Bacteroides extracellular peptidases 
have been identified. Gibson et al. have characterized 3 
major proteases in a strain of B. fragilis. Pl is a 
serine protease, and is located intracellularly and in the 
periplasm. P2, a metalloprotease, and P3, a cysteine 
protease, are located in the outer membrane (32). The 
activity of these proteases was found to progressively 
transfer into the culture medium during stationary phase. 
Whether this transfer represented active enzyme secretion 
or simple cell degradation was not determined (31). In a 
study of proteolytic gut bacteria, they found Bacteroides 
to be well represented (51). 
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Since protein catabolism is not required for growth, 
the protease production found in Bacteroides is 
intriguing. The ability to use both carbohydrates and 
peptides for protein and lipid synthesis may give an 
advantage to these organisms in the colon, where host 
dietary intake is in constant flux. For example, Smith 
and Salyers have found that B. thetaiotaomicron can ingest 
amino acids and incorporate them de novo into proteins and 
lipids (110). Bacteroides proteases may also be involved 
in the pathogenesis of these organisms, as discussed in 
Miscellaneous Virulence Factors (Chapter 2). 
Epidemiology 
Bacteroides are the predominant anaerobes in the 
human gut (93), and account for approximately 21% of all 
colonic isolates (58). As such, they are considered to be 
important contributors to the maintenance of the colonic 
ecosystem. Bacteroides produce fermentation products that 
serve as nutrients for other colonic microflora as well as 
the host {85), and may also contribute to colonic dietary 
fiber digestion {86). 
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While Bacteroides play a prominent role in the 
colonic ecosystem of their host, they frequently become 
opportunistic pathogens when released into the surrounding 
tissues. They are the predominant anaerobic isolates from 
abdominal infections, skin and subcutaneous wounds, and 
abscesses proximal to the rectum {13). The reason for the 
frequent appearance of Bacteroides in these infections may 
be due in part to their high concentration in the colon. 
However, virulence factors also play a significant role in 
their pathogenicity {see Virulence Factors, Chapter 2). A 
retrospective study by Brook on the distribution of 
different Bacteroides species in clinical isolates over a 
12 year period at Walter Reed Army Medical Center in 
Washington, DC and the Navy Hospital in Bethesda, MD drew 
several conclusions {12). Among them, out of 15844 
bacterial cultures collected from patients at these 2 
hospitals in the 12 year period, Bacteroides were isolated 
from 19% of them. B. fragilis accounted for 63% of all 
Bacteroides isolates; B. thetaiotaomicron for 14%; B. 
vulgatus and B. ovatus for 7% each; B. distasonis for 6%; 
and B. uniformis for 2%. Of the five major foci for 
Bacteroides infection, B. fragilis was isolated with the 
greatest frequency: 78% of all Bacteroides species from 
blood cultures, 69% from wounds, 65% from abscesses, 59% 
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from abdominal infections, and 56% from pelvic infections. 
Members of the genus were also regularly isolated from 
chest and genitourinary tract infections, cysts, bile, and 
tumors. Bacteroides septicemia (i.e., persistent invasion 
of the blood stream by bacteria) frequently had an 
unfavorable outcome, with an overall mortality of 24% 
(14). 
Infections involving Bacteroides are often 
polymicrobial in nature. In addition to Bacteroides, 
rectal abscesses also regularly contain Staphylococcus 
aureus, streptococcus pyogenes, or Enterobacteriaceae 
(especially E.coli). Likewise, abdominal abscesses 
containing Bacteroides frequently also contain E. coli or 
other Enterobacteriaceae (13). An exception to this is in 
Bacteroides septicemia, where infections can be poly- or 
monomicrobial (14,19). Although the organisms co-isolated 
with Bacteroides are usually a part of the normal 
microflora surrounding the infection foci, their 
appearance along with Bacteroides is probably not 
coincidental. Synergy between Bacteroides and E. coli, 
Klebsiella pneumoniae, Pseudomonas aeruginosa, s. aureus, 
S. pyogenes, and enterococci has been noted. In vivo 
studies using murine models have found that this synergy 
can lead to a lowered Lethal Dose50 (16), an enhanced 
ability to form abscesses (15,16), an induction of at 
least 1 Bacteroides virulence factor (i.e., capsule 
formation) (15) and an increase in the survival of 
organisms in abscesses (11). 
Bacteroides possess a wide array of tools with which 
they cause and maintain infections. These include 
virulence factors, antibiotic resistance mechanisms, and 
horizontal gene transfer factors. 
virulence Factors 
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A virulence factor is defined as a bacterial 
attribute or product that provides the organism with a 
selective advantage for establishing infection or ensuring 
its own reproduction (44). Known or putative bacterial 
virulence factors include extracellular capsules, 
fimbriae, outer membrane proteins, lipopolysaccharides, 
proteases, nucleases and other enzymes, metabolites and 
exotoxins. Bacteroides possess both confirmed and 
putative virulence factors. 
Extracellular capsule. Perhaps the best-studied 
Bacteroides virulence factor is their extracellular 
mucopolysaccharide capsule, common to all Bacteroides 
species with the possible exception of B. distasonis 
(3,15). The capsule is not a homogenous entity, showing 
variation at the species and strain levels. Pantosti et 
al. have identified 2 antigenically distinct capsular 
polysaccharides in a single B. fragilis strain, 
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polysaccharide A and polysaccharide B, while Patrick et 
al. have classified large-capsule, small-capsule and 
electron-dense capsule populations in different B. 
fragilis strains (50,72,73,116). B. thetaiotaomicron and 
B. vulgatus isolates possessing unique capsule 
configurations have also been identified. These isolates 
displayed numerous strands of polysaccharide extending 
from the cell surface, and were highly resistant to host-
mediated killing (7). 
Capsule formation is induced by unknown signals 
present in vivo: animal passage leads to increased 
encapsulation, as does co-infection with aerobic bacteria. 
Conversely, serial subculture reduces capsular expression 
(15,108). In vivo, the capsule appears to enhance 
infectivity, since intraperitoneal injections of 
encapsulated B. fragilis strains alone produce abscesses 
in rats, while unencapsulated strains usually require co-
infection with aerobic bacteria (64). The capsule itself 
is a causative agent, since capsule material alone can 
stimulate intra-abdominal abscess formation in rats (64). 
Capsules also influence the host-mediated response to 
Bacteroides infection. Unencapsulated strains have 
increased susceptibility to host-mediated opsonophagocytic 
killing (80,108), and Bacteroides capsular preparations 
alone can inhibit polymorphonuclear leukocyte metabolism, 
chemotaxis (27), and phagocytosis (119). Capsule 
preparations also confer immunity to subsequent 
Bacteroides challenge (100). 
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Adhesion of bacterial cells to host surfaces (ce11-
ce11 interactions). Adhesion of gram-negative bacteria to 
mucosal surfaces, resulting in enhanced bacterial 
retention and thus infectivity, is generally associated 
with fimbriae (44). Pruzzo et al. found that B. fragilis 
fimbriae increased non-specific bacterial cell adherence 
to both epithelial cells and neutrophils, which in turn 
led to increased phagocytosis by the latter (75,76). The 
net contribution of these structures upon the virulence of 
B. fragilis is consequently unclear. Oyston and Handley 
reported that the capsule itself may play a significant 
role in Bacteroides adhesion (66), while Guzman et al. 
have established that 48% of B. fragilis clinical isolates 
studied possessed a neuraminidase-dependent adhesin that 
promoted attachment to mammalian epithelial cells, but not 
human polymorphonuclear leukocytes (40). since B. 
fragilis produces neuraminidase, this adhesin may be 
physiologically important for cell-cell attachment 
(33,52). 
Toxins. While B. fragilis contains 
lipopolysaccharide (LPS) in its cell wall, the LPS has a 
low endotoxic activity when compared with enterobacterial 
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LPS (121). While not toxic, Zaleznik et al. found that B. 
fragilis LPS is a potent abscess inducer, and thus can be 
classified as a virulence factor (125). 
Bacteroides do produce exotoxins. Weikel et al. 
reported that B. fragilis isolates from patients 
exhibiting diarrhea were enterotoxigenic (120). In 
separate studies, Pantosti et al. and Van Tassell et al. 
demonstrated that human and animal clinical isolates of B. 
fragilis frequently produced exotoxins that were both 
entero- and cytotoxic (71,118). 
Miscellaneous virulence factors. other factors which 
may contribute to Bacteroides virulence include: (~) 
succinic acid, a metabolic by-product of Bacteroides 
glucose catabolism. In vitro, succinic acid inhibited 
polymorphonuclear leukocytes in a system that mimicked 
conditions found in clinical abscesses. Killing of E. 
coli was eliminated, and both random migration and 
directed chemotaxis of leukocytes was impaired (82,83). 
(~) Farias et al. reported a strain of B. fragilis that 
produced 2 bacteriocidal proteins. These proteins, termed 
fragilisins, could give strains producing them a 
competitive advantage during pathogenesis (26). (~) 
McGregor et al. showed that many clinical isolates of B. 
fragilis and B. thetaiotaomicron produced phospholipase c. 
This enzyme hydrolyzes lecithin, a cell membrane 
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component, and may contribute to host tissue damage and 
enhance bacterial invasiveness (55). (~) The production 
of proteases have already been discussed in conjunction 
with Bacteroides metabolism. Bacteroides do not require 
amino acids for growth, yet produce many proteases. 
Proteases are likely virulence factor candidates, as they 
have the potential to degrade a variety of host proteins 
important in defense and cell wall assembly. In one case, 
a metalloprotease has been found to be enterotoxigenic 
(57) . (~) Iron-repressible outer membrane proteins 
(IROMPs). Iron is necessary for bacterial growth, and 
must be collected from the extracellular environment. 
IROMPs are present in the-outer membranes of B. fragilis 
grown in iron-poor media (44,65), and may give Bacteroides 
a competitive advantage over other bacteria in the iron-
poor milieu of the colon. 
Antibiotic Resistance Mechanisms 
The aforementioned virulence factors act together 
coordinately to increase the pathogenicity of Bacteroides 
throughout the course of an infection. In contrast, 
antibiotic resistance, while adding to the overall 
virulence of an organism, typically does not come into 
play until an infection has been established and treatment 
initiated. (An exception to this may be the intermittent 
exposure to "naturally" produced antibiotics, such as 
14 
penicillin and streptomycin.) Thus, while being 
intrinsically different from other virulence factors, 
antibiotic resistance does influence the final outcome of 
an infection (46). 
Bacteroides are universally resistant to 
aminoglycosides (17). Most strains are also resistant to 
tetracycline, and most B-lactam drugs including the 
penicillins and many cephalosporins (13,86). In addition, 
Garcia-Rodriguez et al. found varying levels of resistance 
to cefoxitin (2-63 %), clindamycin (0-34%), and 
piperacillin (12-21 %) in a recent, retrospective world-
wide survey. Chloramphenicol, while no longer generally 
used to treat Bacteroides infections due to its potential 
for toxicity, was nevertheless found active against most 
clinical isolates (30). Imipenem and metronidazole, along 
with B lactam/B lactamase inhibitor combinations (e.g., 
amoxicillin/clavulanic acid, ampicillin/sulbactam, 
ticarcillin/clavulanate and piperacillin/tazobactam) are 
thus considered the best therapeutic choices for the 
treatment of Bacteroides infections. 
The antibiotic resistance mechanisms found in 
Bacteroides vary widely according to the class of drug 
under consideration. Aminoglycoside resistance is due to 
a lack of drug transport into the cell (17). Resistance 
to penicillins/cephalosporins is primarily mediated 
through the production of a variety of B-lactamases 
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(47,63,114), while ribosomal protection mechanisms account 
for clindamycin (78) and tetracycline (61) resistance. 
Horizontal Gene Transfer Factors 
Many bacterial plasmids, and occasionally chromosomal 
factors, are transferable to adjacent cells by a mating 
process collectively known as conjugation. These transfer 
factors often carry antibiotic resistance genes, and thus 
can account for the rapid conversion of an antibiotic-
sensitive bacterial population to a resistant one. 
Examples of Bacteroides transferable resistance factors 
are: pBFTMl0 ( 15 kb) ( 113) , pBF4 ( 41 kb) ( 105) , and pBI136 
(82 kb) (109), all of which bear clindamycin resistance 
genes on related mobile DNA elements; pRYC3373 (40 kb) 
which carries a chloramphenicol resistance gene (54); the 
family of chromosomal factors known as Tet Elements (70-
200 kb), which carry tetracycline resistance genes, with 
or without closely linked erythromycin resistance genes 
(4,102). B. fragilis strain TAL4170 (22), and B. 
thetaiotaomicron UNl0l (77), also appear to possess 
chromosomal cefoxitin resistance transfer factors. 
Some conjugative (i.e., transferable by a 
conjugation-type mechanism) factors appear to carry no 
adventitious genes, and are termed cryptic. While the 
functions of cryptic transfer factors in Bacteroides are 
unknown, their widespread occurrence suggests they do play 
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a role in horizontal gene transfer. Cryptic transfer 
factors may carry genes that confer a growth advantage 
only in specific environments, and have the potential to 
act in conjunction with mobile DNA elements to acquire and 
then transfer new adventitious genes. Among the 
characterized Bacteroides cryptic transfer factors are 
XBU4422, a 65 kb chromosomal element related to the Tet 
Elements (107), the plasmids pBB-51 (4 kb) (104,117), and 
pBI143 (3 kb) (48), and the chromosomal insertion elements 
NBUl and NBU2 (10-12 kb) (48,106). A cryptic transposon, 
Tn4399 (10 kb), has also been described (42,43,59). 
Conjugative transfer of DNA is a multi-step process 
that requires many functions including mating pair 
formation and maintenance, and DNA processing in both the 
host and recipient cells (28,124). In the case of large 
transferable plasmids such as F and R751 from the family 
Enterobacteriaceae, most of these functions are supplied 
by the plasmid, and they are referred to as conjugal or 
self-transferable plasmids. In contrast, small plasmids 
like ColEl from E.coli perform only minimal DNA 
processing, while other required functions are provided by 
a co-resident conjugal plasmid. These small plasmids are 
referred to as mobilizable plasmids, and cannot transfer 
unassisted. Mobilization may thus be seen as a process in 
which the mobilized plasmid fortuitously uses the 
conjugation system of the co-resident conjugal plasmid. 
17 
Both conjugal and mobilizable plasmids that have been 
characterized possess 2 components absolutely required for 
transfer: a cis-acting region of DNA known as the origin 
of transfer (oriT), and 1 or more trans-acting DNA 
processing proteins, including a DNA relaxase. Relaxases 
bind at their cognate oriT, and then specifically cleave 1 
strand of DNA at a nick site (nic) within oriT. After 
nicking, the strand is transferred to the recipient cell 
(8,25,28,29,45,49,115,124). This protein-DNA recognition 
has invariably been shown to be unique for a given plasmid 
class (i.e., the nicking proteins of 1 plasmid type will 
not recognize the oriT of other plasmid types). 
Possibly the best characterized DNA processing model 
system is that of RP4, a conjugal IncPa broad-host-range 
plasmid. The generation of a single DNA strand destined 
to be transferred to a recipient cell begins when complex 
nucleoprotein structures called relaxosomes form in a 
defined sequence at the oriT of RP4 (67). First, TraJ 
recognizes, and then binds, to the right half of a 19 bp 
inverted repeat sequence within the oriT (126). Then, 
TraI recognizes a 6 bp sequence between nic and the TraJ-
binding site, and joins the TraJ-oriT nucleoprotein 
complex (69). TraH specifically interacts with both TraI 
and TraJ, and is proposed to stabilize the relaxosome 
(67). Another protein, TraK, acts to enhance nicking at 
oriT (29). Several molecules of TraK have been found to 
bind to a region of bent DNA adjacent to the nic site, 
resulting in a local alteration of DNA superhelicity 
{127). Once the relaxosome is formed, TraI cleaves a 
defined strand of 
DNA at nic, after 
which TraI becomes 
covalently 
attached to the 5 1 
phosphoryl end 
{69). TraI is 
also thought to 
act in transfer 
termination in an 
undefined way 
Schema tar proposed oucleo-
protein interactions at the 
RP4 oriT 
{70). This sequence of events leading to single-strand 
DNA transfer is not unique to RP4. Similar DNA-protein 
interactions at oriT have been found in other plasmid 
transfer systems as well (8,36,45,49,95). 
18 
The sequence of events leading up to the transfer of 
DNA has not been fully elucidated in any Bacteroides 
plasmid to date. However, the RP4 relaxosome model may be 
applicable to at least some Bacteroides factors. The 
transfer regions of 3 Bacteroides plasmids have been 
partially characterized, and all possess some components 
analogous to those of the RP4 system. In the first 
example, Hecht et al. have identified 2 genes in the B. 
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fragilis clindamycin resistance plasmid pBFTMlO, btgA and 
btgB, that are required for mobilization in E.coli when 
co-resident with R751, and for self-transfer in B. 
fragilis (41). Both of these genes, and a cis-acting oriT 
as well have been cloned. BtgA, the protein product of 
btgA, has been found to specifically bind oriTpBFTMio, and 
is thought to play a part in the initiation of transfer 
(D.W. Hecht, personal communication). In the second 
example, Murphy and Malamy have characterized the 
mobilization region of the B. fragilis conjugative 
transposon Tn4399 (59). They have identified 2 genes 
required for mobilization, mocA and mocB, and an oriT 
(59). MocA, and MocB are both necessary for site- and 
strand-specific nicking at oriTTn 4399 ( 60) . Finally, Li et 
al. have characterized the mobilization region of the 
Bacteroides chromosomal insertion element NBU 1 (48). 
They have identified an oriT, and a gene, mob, required 
for mobilization in Bacteroides when co-resident with a 
conjugal Tet Element. In this case, the protein product 
of mob bears no homology to known relaxases, but may 
participate in DNA nicking at oriT. 
CHAPTER 3 
MATERIALS AND METHODS 
chemicals 
Chemicals were purchased from Sigma Chemicals or J.T. 
Baker unless otherwise noted. 
Bacterial strains 
The bacterial strains and their genotypes are given 
in table 1. 
B. thetaiotaomicron BT4001 is a spontaneous 
rifampicin-resistant mutant of B. thetaiotaomicron type 
strain 5482 and was generously provided by Abigail Salyers 
of the University of Illinois, Urbana. B. fragilis TM4000 
is also known as B. fragilis type strain 638rfm. B. 
fragilis TM4.23 is a variant of B. fragilis TM4000 that 
contains the TM230 chromosomal Tet element. TM4000 and 
TM4.23 were generously provided by Michael Malamy of Tufts 
University. B. fragilis LV22 was isolated at a hospital 
in Las Vegas, Nevada, and is part of a collection in the 
D.W. Hecht laboratory. 
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Table 1.--Bacterial strains 
Strain 
Bacteroides spp, 
B. fragilis LV22 
B. fragilis TM4000 
B. fragilis TM4.23 
B. thetaiotaomicron 
BT4001 
B. thetaiotaomicron 
BT22.47 
Escherichia coli 
E.coli HB101 
E.coli DHScx 
E. coli DW1030 
Relevant 
phenotypes a 
Tcr, Rifr , B. 
fragilis TM4000 + 
TMP230 Tet Element 
Smr, recA13 
Nalr, recAl 
Spr, recA13 
source 
This study 
M. Sebald, Pasteur 
Institute, Paris France, 
as 638rfm 
Hecht, D.W. & Malamy, M. 
(42) 
Shoemaker, N. & Salyers, 
A. (106) 
This study 
Sambrook et al. (90) 
Gibco BRL, Gaithersburg, 
MD USA 
Robillard et al. (81) 
Note:aNalr, Rifr, Spr, Smr, and Tcr indicate resistance to nalidixic 
acid, rifampicin, spectinomycin, streptomycin and tetracycline, 
respectively. 
Bacterial Media 
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Bacteroides were grown in BHIS medium, (3.7% (w/v) 
BHI medium (BBL), 0.5% (w/v) yeast extract (Difeo), 
0.0005% (w/v) hemin) at 37° C under anaerobic conditions 
(5% CO2 , 10% H2 , 85% N3 ). E.coli was grown in modified 
Luria (ML) medium (1.0% (w/v) tryptone (Difeo), 0.5% (w/v) 
yeast extract (Difeo), 0.5% (w/v) NaCl, 0.2% (w/v) K2HP04 ) 
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at 37° c. Agar (Difeo) was added to BHIS and ML broths at 
1.5% (w/v) for plating. 
Antibiotics 
Antibiotic concentrations used for selection of 
strains and plasmids were: ampicillin (Marsam 
Pharmaceuticals), 200 µg/ml; chloramphenicol, 40 µg/ml; 
clindamycin (Upjohn), 12 µg/ml; gentamicin (Elkins-Sinn), 
40 µg/ml; kanamycin, 50 µg/ml (25 µg/ml when used in 
combination with other antibiotics); streptomycin, 50 
µg/ml; spectinomycin, 50 µg/ml; and tetracycline, 10 
/ µg/ml (E. coli) or 5 µg/ml (Bacteroides). E. coli 
strains containing R751 were grown on Meuller-Hinton 
medium supplemented with 10 µg/ml trimethoprim. 
Ampicillin, clindamycin, kanamycin, streptomycin, and 
spectinomycin were dissolved in water, filter-sterilized, 
and stored at -20° c. Gentamicin was supplied in a 
sterile, aqueous solution and stored at room temperature. 
Tetracycline was dissolved in 95% (v/v) EtOH {Aldrich) and 
stored at -20° c. Trimethoprim was dissolved in 70% (v/v) 
EtOH {Aldrich) and chloramphenicol was dissolved in 95% 
(v/v) EtOH (Aldrich). Both were stored at 4° c. Aqueous 
antibiotic solutions were used within 1 year of 
preparation; ethanolic solutions were used within 2 weeks. 
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Whole-cell DNA Preparation 
Whole-cell DNA was prepared essentially as described 
by Saito and Muira (84). A 10 ml volume of saturated 
Bacteroides or E.coli culture was transferred to a 40 ml 
Oakridge tube, and collected by centrifugation (7.8 
kRCFave, 10 min, at 4° C). The cells were washed once in 
50 ml of saline-EDTA (0.15 M NaCl, 0.1 M EDTA pH 8.0), 
collected by centrifugation, and suspended in 5 ml of 
saline-EDTA supplemented with 4 mg of lysozyme. The cells 
were incubated 20 min at 37° C and then quick-frozen in an 
EtOH/dry ice bath. 5 ml of Tris-sos buffer (0.1 M Tris pH 
9.0, 1% sodium dodecyl sulfate, 0.1 M NaCl) was added, and 
the cells thawed with gentle mixing in a 50° c water bath. 
The lysate was then diluted with 5 ml of saline-EDTA. 5 
ml of phenol (United States Biochemical) :chloroform: 
isoamyl alcohol (25:24:1) was added to the lysate, the 
mixture briefly shaken and placed on ice for 15 min. The 
lysate was then centrifuged at 11 kRCFave for 30 min at 20° 
C. The aqueous phase was -transferred to a fresh Oakridge 
tube. The phenol extraction step was repeated once if 
Bacteroides cells were used. 1 volume of 2-propanol was 
added and the mixture incubated 30 min at R.T. The 
precipitated nucleic acids were then collected by 
centrifugation (15.6 kRCFave, 15 min, 20° C), the supernate 
removed, and the nucleic acids dried in a vacuum 
desiccator for 30 min at room temperature (R.T.). They 
were then dissolved in 1 ml TE (30 mM Tris pH 8.0, 5 mM 
EDTA) supplemented with 40 µg/ml of DNAse-free RNAse A, 
and incubated 30 min at 37° c to digest RNA. 
small-scale Plasmid DNA Preparation 
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Plasmid DNA for endonuclease restriction analysis as 
well as some DNA sequencing was prepared by miniprep 
alkaline lysis as described by Sambrook et al. (88). In a 
microcentrifuge tube, 1.5 ml of saturated E.coli culture 
or 3.0 ml of saturated Bacteroides culture was briefly 
spun in a microcentrifuge. The supernate was then 
removed, and the cells suspended in 100 µl of Solution 1 
(50 mM glucose, 10 mM EDTA, 25 mM Tris pH 8.0). To lyse 
the cells, 150 µl of fresh Solution 2 (0.2 M NaOH, 1% 
(w/v) sodium dodecyl sulfate) was added, mixed gently, and 
placed on ice for 5 min. 150 µl of Solution 3 (5 M 
potassium acetate, pH 4.8) was added, mixed gently, and 
the mixture again iced for 5 min. The mixture was then 
centrifuged for 15 min at 4° c. The supernate, 
containing plasmid DNA, cellular RNA, and protein, was 
transferred to a new microcentrifuge tube and extracted 
once with phenol (United States Biochemical) :chloroform 
(1:1). If a Bacteroides strain was lysed, the phenol 
extraction was repeated once. The aqueous phase was then 
transferred to a new microcentrifuge tube, and 2 volumes 
of 95% (v/v) EtOH (Aldrich) added. The solution was kept 
25 
at -70° C for 5 min, and the nucleic acids collected by 
centrifugation in a microcentrifuge. The supernate was 
drained, the nucleic acid pellet washed with ice-cold 70% 
(v/v) EtOH {Aldrich), and the pellet dried for 5 min at 
37° c. The nucleic acids were then dissolved in TE (30 mM 
Tris pH 8.0, 5 mM EDTA) supplemented with 40 µg/ml of 
DNAse-free RNAse A, and the solution incubated for 30 min 
at 37° c to digest RNA species. 
When preparing mini-prep plasmid DNA for sequencing, 
the following modifications were made: (a) 5 ml of 
bacterial culture was used instead of 1.5 ml; (b) cleared 
lysates were extracted twice with phenol:chloroform, 
followed by an extraction with chloroform. 
Large-scale Plasmid DNA Preparation 
Large-scale plasmid DNA was prepared by 2 methods: 
(a) Qiagen affinity column purification (Qiagen Corp), as 
instructed by the manufacturer; (b) large-scale alkaline 
lysis with CsCl equilibrium gradient purification 
essentially as described by Sambrook et al. (90). The 
latter procedure was performed as follows: a 100 ml 
culture of E.coli, containing the plasmid to be purified, 
was grown to saturation with antibiotic added for plasmid 
maintenance. The cells were collected by centrifugation 
(10.2 kRCFave, 10 min, 4° C), suspended in 10 ml of 
Solution 1 {50 mM glucose, 25 mM Tris pH a.o, 5 mg/ml 
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lysozyme, 10 mM EDTA), transferred to a 40 ml Oakridge 
tube, and incubated for 5 min at R.T. To lyse the cells, 
20 ml of fresh Solution 2 (0.2 M NaOH, 1% (w/v) sodium 
dodecyl sulfate) was added and mixed gently, and the 
solution incubated at R.T. for 10 min. 15 ml of Solution 
3 (5 M potassium acetate, pH 4.8) was added, mixed, and 
the solution placed on ice for 10 min. The mixture was 
then centrifuged for 30 min at 26.7 kRCFa=, 4° c. The 
supernate was transferred into two 40 ml Oakridge tubes, 
and 0.6 volumes of 2-propanol added to each tube to 
precipitate nucleic acids. The tubes were incubated for 
15 min at R.T. and centrifuged for 30 min at 26.7 kRCFave, 
20° c. The supernates were then drained, and the nucleic 
acids dissolved in 7.4 ml TE {30 mM Tris pH 8.0, 5 mM 
EDTA). To isolate and purify the plasmid DNA, CsCl 
equilibrium gradient separation was performed. To 7.4 ml 
of nucleic acid solution, 1 g of CsCl and 0.8 ml of 10 
mg/ml ethidium bromide were added, mixed, and centrifuged 
for 16 hat 183.2 kRCFmax, 20° C. The plasmid bands were 
then harvested from the CsCl gradients by side puncture, 
pooled, and the ethidium bromide extracted with 2-propanol 
saturated with l0X SSC (1.5 M NaCl, 0.15 M trisodium 
citrate pH 7.0). The DNA was then precipitated in a 40 ml 
Oakridge tube by adding an equal volume of TE and 2 
volumes of 95% (v/v) EtOH (Aldrich) and overnight storage 
at -20° c. The precipitated DNA was then collected by 
centrifugation {15.6 kRCFave, 30 min, at 4° C), the 
supernate removed, the pellet dried in a vacuum 
desiccator, and then suspended in 2 ml TE. 
Restriction Endonuclease Digestion 
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Restriction endonuclease digestions were performed as 
described in Sambrook et al. {89), using enzymes and 
reaction buffers supplied by New England Biolabs, Promega, 
or Stratagene. 
s1 Nuclease Digestion 
In some instances, Sl nuclease {Promega) was used to 
generate blunt-ended DNA prior to ligation. Digestions 
were typically done in a 50 µl volume in Sl nuclease 
buffer (0.25 M NaCl, 15 mM acetic acid, 15 mM potassium 
acetate pH 4.5, 1 mM ZnSO4 , 5% (v/v) glycerol) using 25 
units of enzyme. The mixture was incubated for 1 hat 
R.T. and the DNA purified by agarose gel electrophoresis. 
Agarose Gel Electrophoresis 
Gel electrophoresis was performed using agarose 
concentrations of 0.6%-2.0% according to DNA fragment 
size, and lX SB3 running buffer (37.5 mM Tris, 8.0 mM 
sodium acetate, 0.8 mM EDTA, pH 7.9). Gel slabs were then 
stained with 0.5 µg/ml of ethidium bromide and the DNA 
visualized by short-wave UV light. 
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Extraction of DNA from Agarose Gels 
DNA fragments that were to be used in molecular 
cloning procedures were generally purified by agarose gel 
electrophoresis and then extracted from the agarose with 
the Gene-Clean II System (Bio 101) if greater than 500 bp 
in size, or with the Wizard PCR Prep Purification System 
(Promega) if less than 500 bp. Both systems were used as 
instructed by their manufacturers. 
DNA Ligation 
Cohesive-end ligation of DNA fragments was performed 
as described by Sambrook et al. (91), using 1.5 U of T4 
DNA ligase and buffer supplied by New England Biolabs or 
Promega, for 4 hr or overnight at 16° c. 
Blunt-end ligations were performed as described by 
Sambrook et al. (91), using T4 DNA ligase, supplied by New 
England Biolabs or Promega, and blunt-end ligation buffer 
{33 mM Tris pH 7.6, 3 mM MgC12 , 5% (w/v) PEGS000, 0.1 mM 
ATP, and 5 mM DTT), overnight at R.T. 
Prior to ligation, the vector DNA was usually de-
phosphorylated at its 5 1 ends using calf intestinal 
alkaline phosphatase as recommended by the supplier (New 
England Biolabs). Ligated DNA was routinely transformed 
to competent E. coli DH5a. 
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Preparation and Transformation of competent E, coli 
E.coli strains were made competent prior to DNA 
transformation using two protocols. The E.coli strains 
DH5a and HBl0l were used on a regular basis for the 
transformation of DNA. Consequently, competent cell 
preparations of these 2 strains were prepared and stored 
frozen, using the following method: from a bacterial 
culture grown to saturation, 1 ml of cells were sub-
cultured to 100 ml of pre-warmed Y broth (0.5% (w/v) yeast 
extract (Difeo), 2% (w/v) tryptone (Difeo) and 0.5% (w/v) 
MgSO4 , adjusted to pH 7.6 with KOH) and incubated at 37° c 
with vigorous shaking, until the density of cells reached 
an OD5~ of 0.48. The cells were then chilled on ice for 5 
min, and collected by centrifugation (3.7 kRCFave, 10 min, 
4° C). The supernate was then drained, the cells 
suspended in 40 ml of ice-cold TBFl solution (30 mM 
potassium acetate, 100 mM KCl, 10 mM CaC12 , 50 mM MnC12 , 
and 15% (v/v) glycerol, adjusted to pH 5.8 with acetic 
acid) transferred to a 40 ml Oakridge tube, and chilled on 
ice for 5 min. The cells were collected by centrifugation 
(7.8 kRCFave, 10 min, 4° C), the supernate removed, and the 
cells suspended in 4 ml of TBF2 solution (10 mM MOPS, 75 
mM CaC12 , 10 mM KCl, and 15% (v/v) glycerol, adjusted to 
pH 6.5 with KOH) and chilled on ice for 15 min. The cells 
were then frozen at -70° c. To transform, frozen cells 
were thawed and placed on ice for 10 min. 25-100 ng of 
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DNA was then added to 50 µl of cells, the cells placed on 
ice for 2 min, incubated at 42° C for 1.5 min, then placed 
on ice again for 2 min. To rescue the cells, 200 µl of 
R.T. soc medium {2% (w/v) tryptone {Difeo), 0.5% (w/v) 
yeast extract (Difeo), 10 mM NaCl, 2.5 mM MgC1 2 , 10 mM 
MgSO4 and 20 mM glucose) was added, and the cells 
incubated at 37° c for 1 h with vigorous shaking. 100 µl 
of cells were then plated to selective medium and the 
plate incubated overnight. 
For strains of E.coli other than DH5a and HBl0l 
that were not routinely transformed, competent cell 
preparations were made and used immediately following a 
modification of the method of Cohen et al. (20): a 
saturated E. coli broth culture was sub-cultured to pre-
warmed ML broth and incubated at 37° c with vigorous 
shaking until the OD550 reached 0.5. The cells were then 
collected by centrifugation (7.8 kRCFave, 10 min, 4° C), 
the supernate drained, the cells suspended in 1 volume 
ice-cold 30 mM CaC12 solution and placed on ice for 30 
min. The cells were then collected by centrifugation as 
above, the supernate drained, and the cells suspended in 
0.1 volume of 75 mM CaC12 • 200 µl of these cells were then 
added to 25-100 ng of DNA and placed on ice for 60 min. 
The cells were then incubated at 42° C for 5 min, and 
again placed on ice for 30 min. To rescue the cells, they 
were mixed with 5 ml of R.T. ML broth and incubated for 
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2 hat 37° C with vigorous shaking. A 100 µl aliquot of 
this cell suspension was then plated to selective medium, 
and the plate incubated overnight. 
Plasmid constructions (Table 2) 
pGAT400. pGAT400 is an E. coli-Bacteroides shuttle 
plasmid whose characteristics have been previously 
described by Hecht and Malamy {42). It is a fusion of the 
E.coli plasmid pDG5 (itself a fusion of the ColEl 
replicon, the ampicillin resistance gene, bla, and the RK2 
origin of transfer, oriTRK2 (37)) and the B. fragilis 
conjugative (i.e., transferable by a conjugation-type 
mechanism) plasmid pBFTMl0 {113) (fig. 1). pGAT400 
confers ampicillin resistance in E. coli owing to the bla 
gene, and clindamycin resistance in Bacteroides, due to a 
clindamycin resistance gene located on the resident 
transposon of pBFTMl0, Tn4400 (81). 
In pGAT400, both pDG5 and pBFTMl0 have active 
transfer properties. Thus, when co-resident with an 
IncPa conjugal (i.e., self-transferable) plasmid such as 
RK2 or pRK231, pGAT400 can be mobilized from E.coli to E. 
coli (34), or to Bacteroides (35). This mobilization is 
due to the transfer proteins of pRK231 acting in trans 
upon oriTRK2 of pDG5. pBFTMl0 also has a transfer region 
that is comprised of a cis-acting origin of transfer, 
Table 2.--Plasmids 
Plasmid 
R751 
F'lac 
pACYC184 
pGEM7Zf(+) 
pBR322 
pBR328 
pBR328ll 
pGAT400 
pGAT400llBgl-
II 
pGAT400llori 
pJA-lla 
pJA-223B 
pJA-7ZT 
pLV22a 
pTJ47-1 
pTJ47-3 
pTJinsla 
pTJins3a 
Relevant phenotypes and 
characteristics a 
IncpB, Tra •, Tmpr 
IncFI, Tra•, lac• 
Mob-, Ap', deletion derivative of 
pBR328 
(Tra-), (Ccr), Mob-, Apr, deletion 
derivative of pGAT400 
(Tra-), (Cc'), Mob-, Apr, deletion 
derivative of pGAT400 
btgA (pBFTMlO) cloned into pETllD 
btgB (pBFTMlO) cloned into pKK223 
pBFTMlO oriT cloned into 
pGEM7Zf (+) 
LV22 native plasmid 
( Tra•), Mob•, Ap', 
pLV22a::pGAT400llBglII fusion 
(Tra•), Mob•, Ap', 
pLV22a::pGAT400llBglII fusion 
Apr, pLV22a ligated into the 
pGEM7Zf(+) EcoRI site 
Apr, pLV22a ligated into the 
pGEM7Zf(+) EcoRI site 
Source 
Meyer & Shapiro 
(56) 
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Pasteur 
Institute, Paris, 
France 
Chang and Cohen 
(18) 
Promega Corp. 
Madison, WI 
Bolivar et al. 
(9) 
Covarrubias et 
al. (21) 
This study 
Hecht, D.W. & 
Malamy, M. (42) 
Hecht, D.W. & 
Malamy, M. ( 42) 
M. Malamy, Tufts 
University 
P.J. Arnold 
P.J. Arnold 
P.J. Arnold 
This study 
This study 
This study 
This study 
This study 
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Table 2--continued 
Relevant phenotypes and 
Plasmid characteristics4 Source 
pTJSa Mob•, Tc', pLV22a ligated into the This study 
pACYC184 EcoRI site 
pTJ8 Mob•, Ap', pLV22a ligated into the This study 
pBR3286 EcoRI site 
pB22a Mob•, Ap'' pLV22a ligated to the This study 
3.9 kb pBR322 AatII/BamHI fragment 
pTJ6 Mob•, Cm', pLV22a ligated to the This study 
3.8kb pACYC184 XbaI/BamHI fragment 
pTJ6XB Mob•, Cm', deletion derivative of This study 
pTJ6 
pTJlO (Tra•), (Cc'), Ap'' pLV22a Mob region This study 
ligated into the BglII site of 
pGAT4006ori 
pTJ12 Mob-, Cm', mbpA deletion derivative This study 
pAC7 Mob-, Tc', TnlOOO mutant of pTJSa This study 
pAC18 Mob-, Tc', TnlOOO mutant of pTJSa This study 
pAC38 Mob-, Tc', TnlOOO mutant of pTJSa This study 
pAC39 Mob-, Tc', TnlOOO mutant of pTJSa This study 
pAC49 Mob-, Tc', TnlOOO mutant of pTJSa This study 
pAC67 Mob-, Tc', TnlOOO mutant of pTJSa This study 
pBR7 Mob-, Ap'' TnlOOO mutant of pLV22a This study 
ligated into EcoRI site of pBR3286 
pBR18 Mob-, Ap'' TnlOOO mutant of pLV22a This study 
ligated into EcoRI site of pBR3286 
pBR38 Mob-, Ap'' TnlOOO mutant of pLV22a This study 
ligated into EcoRI site of pBR3286 
pBR39 Mob-, Ap', TnlOOO mutant of pLV22a This study 
ligated into EcoRI site of pBR3286 
pBR49 Mob-, Ap'' TnlOOO mutant of pLV22a This study 
ligated into EcoRI site of pBR3286 
pBR67 Mob-, Ap', TnlOOO mutant of pLV22a This study 
ligated into EcoRI site of pBR3286 
Plasmid 
pTJ347 
pTJ437 
Table 2--continued 
Relevant phenotypes and 
characteristicsa 
Mob•, Cmr, 347 bp pLV22a oriT PCR 
fragment ligated to the 4.1 kb 
pACYC184 SalI/SphI fragment 
Mob•, Cmr, 437 bp pLV22a oriT PCR 
fragment ligated to the 4.1 kb 
pACYC184 SalI/SphI fragment 
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Source 
This study 
This study 
Notes: a Apr, Ccr, Cmr, Tcr and Tmpr indicate resistance to ampicillin, 
clindamycin, chloramphenicol, tetracycline and trimethoprim, 
respectively. XU refers to the ability of a plasmid to transfer by 
a conjugation-type mechanism, while lf1Ql2 refers to the mobilization 
phenotype of a tra- plasmid when co-resident with R751 (and wild-type 
pLV22a, in the cases of pTJ347 and pTJ437). Parenthesis denotes 
phenotypes expressed only in Bacteroides, while no parenthesis 
indicates phenotypes expressed only in E.coli. 
oriTpBFTMJo, and 2 transfer genes, btgA and btgB (41) (D.W. 
Hecht, personal communication). When co-resident with the 
IncPB conjugal plasmid R751, pGAT400 can be mobilized from 
E. coli to E. coli or to Bacteroides by the in trans 
interaction of the R751 transfer apparatus and the pBFTMlO 
transfer region (41). pGAT400 can also transfer from 
Bacteroides to Bacteroides, or to E.coli, through the 
expression of the pBFTMlO transfer region (41,42). 
pGAT400•BglII and pGAT400•ori. pGAT400•BglII is a 
derivative of pGAT400 that has been deleted for the 
transfer genes of pBFTMlO, btgA and btgB, through the 
elimination of the pBFTMlO BglII fragments (42). 
pGAT400•ori is a related plasmid in which the cis-acting 
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Fig. 1. Maps of (A.) pGAT400, (B.) pGAT400 delta BglII and (C.) pGAT400 delta ori. Restriction 
enzymes are as follows: A, AvaI;B, BglII; C, ClaI; E, EcoRI;EV, EcoRV; H, HindIII. bla denotes 
ampicillin resistance ge~e expressed in E. ~oli; Cc denotes clindamycin resistance geneexpressed 
in Bacteroides. Stippled boxes at the left and right ends of Tn4400 are IS4400left and IS4400ti~t, 
respectively. btgA and btgB are transcribed from left to right in pGAT400. · w 
IJl 
36 
oriTpBFTMJo, in addition to btgA and btgB, have been deleted 
from pGAT400 (D.W. Hecht, personal communication) (fig. 
1). In contrast to their parental plasmid, pGAT400, 
pGAT400•BglII and pGAT400•ori cannot be mobilized when co-
resident with R751 in E.coli, and are not transferable in 
Bacteroides. Like pGAT400, pGAT400•BglII and pGAT400•ori 
can still be mobilized from E.coli when co-resident with 
the IncPa plasmid pRK231, due to the oriTRK2 of the pDG5 
portion of these plasmids. The replication and antibiotic 
resistance properties of pGAT400•BglII and pGAT400•ori are 
also identical to pGAT400. 
pGEM7Zf(+), pBR322, pACYC184, and pBR328. 
pGEM7Zf(+), pBR322, pACYC184 and pBR328 have been 
previously described (fig. 2). pACYC184 and pBR328 were 
chosen for use in the mating experiments because of their 
compatible replicons (pl5A in pACYC184 and ColEl in 
pBR328), and because neither pACYC184 (data not shown) nor 
pBR328 (21) can be mobilized when co-resident with 
conjugal IncP plasmids. 
pBR328•. pBR328• was created for use with pACYC184 
in the complementation assays by deleting the tetracycline 
and chloramphenicol resistance genes of pBR328. pBR328 
was digested with MscI/EcoRV and the resulting 3.8 kb 
fragment self-ligated to give pBR328• (fig. 2). pBR328• 
A. bla 
APATSPXBXHEKXASCH BM BASCBS N XM AP 1··---- I I 
B. Cm Tc Cm 
- -
E XB BMSPSA A E 
I I 
C. Tc bla 
ATE BM A AT 
D. Cm Tc bla Cm 
-
E M EV A E 
0.5kb 
Fig 2. Maps of (A.) pGEM7Zf(+), (B.) pACYC184, (C.) pBR322, and 
(Q.:_) pBR328. Restriction enzymes are as follows:~, Ava!; AT, 
AatII; AP, Apa!; BA, BsaWI; BM, BamHI; BS, BstXI; ~, ClaI; ~, 
EcoRI; EV, EcoRV; H, HindIII; K, KpnI; M, MscI; N, NsiI; S, SmaI; 
SA, Sal!; SC, Sac!; SP, SphI; XA, XmaI;- XB, Xbal; XH, XhoI; and 
XM, XmnI. Dotted line indicates pGEM7Zf(+) multiplecloning site. 
bla denotes ampicillin resistance gene; Cm denotes chloramphenicol 
resistance gene; Tc denotes tetracyclineresistance gene. 
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contains the pBR328 replication region and ampicillin 
resistance gene. 
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pJA-lla, pJA-223B, and pJA-7ZT. pJA-lla, pJA-223B, 
and pJA-7ZT were created by P.J. Arnold in the laboratory 
of D.W. Hecht. pJA-lla is a 6.3 kb plasmid that contains 
a 629 bp PCR-generated copy of the pBFTMlO transfer gene, 
btgA, ligated to the large NcoI/BamHI fragment of pETllD. 
Similarly, pJA-223B is a 5.5 kb plasmid that contains a 
993 bp PCR-generated copy of the pBFTMlO transfer gene, 
btgB, ligated to the large EcoRI/PstI fragment of pKK223. 
Finally, pJA-7ZT contains a 304 bp PCR-generated copy of 
the pBFTMlO oriT, cloned into the BamHI site of 
pGEM7Zf(+). 
pTJinsla and pTJins3a. pTJinsla and pTJins3a were 
created by ligating the 5.3 kb EcoRI fragments of pTJ47-1 
and pTJ47-3 respectively, each containing pLV22a and 
IS4400 1etu into the EcoRI site of the pGEM7Zf(+) 
polylinker (figs. 3, 4). 
pTJ5a and pTJS. pTJ5a and pTJ8 were created by 
ligating the 5.3 kb EcoRI fragment of pTJ47-1 that 
contains pLV22a and IS4400 1ett into the unique EcoRI sites 
of pACYC184 and pBR328•, respectively (fig. 3). 
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dotted lines denote cloning vectors (see text for specific 
vectors). Stippled boxes denote IS44001eft. Restriction sites 
named in full represent sites in the pGEM7Zf(+) multiple cloning 
site. Other restriction sites are as follows:~, Aval; AP, ApaI; 
AT, AatII; BS, BstXI; ~, EcoRI; EV, EcoRV; HC, HincII; ~, NsiI; S3, 
Sau3AI; SC, SacI; and XM, XmnI. Arrow denotes pLV22a mobilization 
region. 
A. 
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Fig. 4. Maps of (A.) pTJins3a, (B.) pTJ6, (C.) pTJ6XB and (D.) 
pTJ12. Heavy solidline denotes pLV22a as found in pTJ47-3; 
dotted lines denote cloning vectors (see text for specific 
vectors). Stippled boxes denote IS44001eft. Restriction sites 
named in full represent sites in the pGEM7Zf(+) multiple cloning 
site. Other restriction sites are as follows:~, Aval; AP, 
ApaI; BA, BsaWI; BS, BstXI; ~, EcoRI; EV, EcoRV; HC, HincII; ~, 
NsiI; S3, Sau3AI; SC, SacI; XB, XbaI; and XM, XmnI. Arrow 
denotespLV22a mobilization region. 
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pB22a. pB22a was created by the ligation of the 5.3 
kb AatII/BamHI fragment of pTJinsla that contains pLV22a 
and IS4400 1eft (from pTJ47-1) to the 3.9 kb AatII/BamHI 
fragment of pBR322 (fig. 3). 
~- pTJ6 was created by ligation of the 5.3 kb 
XbaI/BamHI fragment of pTJins3a that contains pLV22a and 
IS4400 1eft (from pTJ47-3) to the 3.8 kb XbaI/BamHI fragment 
of pACYC184 (fig. 4). 
pTJ6XB. pTJ6XB was created to delete IS4400 left and 
regions of pLV22a not required for mobilization. pTJ6 was 
first digested with XbaI/BstXI, and then with Sl nuclease 
to generate blunt ends. The resulting 5.5 kb fragment 
that contains the pLV22a mobilization region was self-
ligated to give pTJ6XB (fig. 4). 
pTJ10. pTJlO was created by ligating the 3.3 kb 
Sau3AI/BamHI fragment of pTJ6, containing the pLV22a 
mobilization region, into the unique BglII site of 
pGAT400•ori (fig. 5). 
pTJ12. pTJ12 was developed to delete the first 32 bp 
of the mbpA coding region and its promoter. It was 
created by digesting pTJins3a with BsaWI, and then cloning 
the resulting 1.4 kb fragment into the XmaI site of the 
EcoRI 
Kpnl 
Smal 
Clal 
Hind Ill 
E E C E B/S3 BS SC HC BamHI/B E 
I... I I I I I I I I 
Tn4400 
1 kb 
Fig. 5. Map of pTJl0. Heavy solid line denotes pLV22a DNA; dotted line represents pGAT400 delta ori 
DNA. Restriction sites named in full represent sites in the pGEM7Zf(+) multiple cloning site. Other 
restriction sites are as follows:~, BglII; BS, BstXI; E, ClaI; §, EcoRI; HC, HincII; SC, Sac!; and 
S3, Sau3AI. Arrow denotes pLV22a mobilization region. 
~ 
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pGEM7Zf(+) polylinker. This fragment contains the pLV22a 
mobilization region excepting the first 32 bp of mbpA and 
its promoter. The fragment was then excised by digestion 
with XbaI/BamHI, and ligated to the 3.8 kb XbaI/BamHI 
fragment of pACYC184 (fig. 4). 
Tn1000 Random Mutagenesis 
Random TnlOOO insertion mutations in the pLV22a 
portion of pTJ5a were generated using a modification of 
the F plasmid mating protocol as previously described 
(39). A broth culture of the donor, E.coli DW1030 
(F'lac) (pTJ5a), and one of the recipient, E.coli HBl0l, 
were grown to saturation. Into 10 ml of pre-warmed ML 
broth, 1 ml of donor and 2 ml of recipient were added, the 
broth incubated at 37° C for 1 h with vigorous shaking, 
and then for an additional 2.25 h with gentle shaking. 
The cell suspension was then serially diluted in lX MPBS 
(8 mM Na2HPO4 , 2 mM NaH2PO4 , 145 mM NaCl, pH 6.9), and 
aliquots of the dilutions plated to ML medium containing 
antibiotic to select for transconjugants (those recipient 
cells that successfully received the target plasmid), 
which now contained mutant target plasmids with random 
insertions of TnlOOO. Each mutant determined to carry an 
insertion in the pLV22a fragment had its internal TnlOOO 
BglII fragments deleted to prevent further transposition 
of TnlOOO. These mutants were designated pACinsert 
number,~ designating the pACYC184 replicon. 
complementation Analyses 
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In order to perform the complementation analysis of 
mutants pAC7, pAC18, pAC38, pAC39, pAC49 and pAC67, a set 
of plasmids containing identically placed insertion 
mutations was constructed. BsaWl fragments internal to 
TnlOOO were deleted from pAC7, pAC18, pAC38, pAC39, pAC49 
and pAC67, leaving 65 bp of TnlOOO DNA at the sites of 
insertion. A 5.4 kb EcoRI fragment from each of these 
mutants, containing pLV22a and the 65 bp of TnlOOO, was 
then cloned into the unique EcoRI site of pBR328~. The 
resulting plasmids were designated pBR7, pBR18, pBR38, 
pBR39, pBR49, and pBR67 respectively, JIB denoting the 
pBR328 replicon. 
Quantitative Bacteroides to E, coli and Bacteroides to 
Bacteroides conjugative Filter Matings 
To determine the transfer frequency (F) of 
conjugative plasmids and Bacteroides chromosomal Tet 
elements, quantitative Bacteroides-E. coli and 
Bacteroides-Bacteroides filter matings were performed as 
previously described (112). Broth cultures of the donor, 
containing the plasmid or Tet element to be assayed for 
transfer, and of the recipient were grown to mid-log phase 
under appropriate conditions. Cultures of Bacteroides 
containing a Tet element were supplemented with 1 µg/ml 
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of tetracycline 4 h prior to mating. The tetracycline was 
then removed immediately before mating by washing the 
cells once with lX MPBS (8 mM Na2HP04 , 2 mM NaH2 P04 , 145 mM 
NaCl, pH 6.9). (Tetracycline induction of Tet elements 
leads to increased transfer of both the elements 
themselves (74) and co-resident conjugative plasmids such 
as pBFTMl0 (104,117).) Donor and recipient cultures were 
then mixed (2.5 ml:2.5 ml) in a Nalgene cellulose nitrate 
disposable vacuum filtration unit and the cells vacuumed 
unto the filter surface. The filter was then aseptically 
transferred to a BHIS plate, and the plate incubated 
anaerobically at 37° C for 18 h. The filter was then 
vigorously washed in lX MPBS for 20 sec to suspend the 
cells. To determine the number of transconjugants/ml 
(those recipient cells that received the transferred 
plasmid or Tet element), the suspension was serially 
diluted in lX MPBS, aliquots of the dilutions plated to 
antibiotic medium for selection of transconjugants, and 
the plates incubated under conditions suitable for growth 
of the recipient strain. The transconjugant colonies were 
then counted. The number of donor cells per ml in the 
input mid-log phase culture was also determined by serial 
dilution and plating. F was then calculated as: 
transconjugants/ml + input donors/ml. 
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ouantitative R751 Mobilization 
To determine the frequency of plasmid mobilization 
(F=b), a broth culture of the donor, E.coli HBl0l 
containing R751 and the plasmid to be assayed for 
mobilization, and one of the recipient, E. coli DW1030, 
were grown to mid-log phase. 0.15 ml of the donor and 
1.35 ml of the recipient were mixed in a 1.5 ml 
microcentrifuge tube, and the cells collected by 
centrifugation. The supernate was removed, the cells 
suspended in 100 µ1 of lX MPBS (8 mM Na2HPO4 , 2 mM NaH2PO4 , 
145 mM NaCl, pH 6.9), transferred to a 25 mm Nalgene GN-6 
cellulose acetate filter supported on ML agar, and 
incubated for 3 hr at 37° c. The filter was then 
vigorously washed in lX MPBS for 20 sec to suspend the 
cells. To determine the number of transconjugants/ml 
(those recipient cells that received R751 or the mobilized 
plasmid), the suspension was serially diluted in lX MPBS. 
Aliquots of the dilutions were then plated to an 
antibiotic medium for the selection of R751 
transconjugants, and also to a second antibiotic medium 
for the selection of mobilized plasmid transconjugants. 
The plates were incubated overnight at 37° C, and the 
transconjugant colonies counted. F=b was then calculated 
as follows: 
transconjugants=b plasmid/ml transconjugantsR75i/ml. 
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E.coli strain construction using IncP Plasmid Mobilization 
Plasmids that are mobilized when co-resident with the 
IncP conjugal plasmids R751 or pRK231, as well as the IncP 
plasmids themselves, were conjugatively shuttled from one 
E.coli strain to second E.coli strain as follows: a 
saturated broth culture of the donor strain, containing 
R751 or pRK231 (and a mobilizable plasmid, when 
applicable), was mixed with an equal volume of saturated 
recipient broth culture. An aliquot of the mixture was 
plated to ML agar and incubated for 8 hat 37° c. A 
portion of the resulting culture was then plated to ML 
medium containing antibiotics to select for 
transconjugants (those recipient cells that received R751, 
pRK231 or the mobilized plasmid as desired), and the plate 
incubated aerobically overnight at 37° c. 
Bacteroides strain construction using pRK231 Plasmid 
Mobilization 
Plasmids containing the pRK231 origin of transfer, 
such as pGAT400 and its derivatives, are efficiently 
mobilized from E.coli to Bacteroides when co-resident 
with pRK231. pRK231 mobilizations were performed by 
mixing a mid-log phase broth culture of donor E.coli, 
containing pRK231 and the plasmid to be mobilized, with an 
equal volume of mid-log phase Bacteroides recipient 
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culture. An aliquot of the mixture was then transferred 
to a BHIS plate and the plate incubated overnight 
aerobically at 37° c. A portion of the resulting culture 
was then plated to BHIS medium containing antibiotics to 
select for transconjugants (those recipient cells that 
received the mobilized plasmid), and the plate incubated 
anaerobically for 48 hat 37° c. 
DNA seguencing 
Nucleotide sequences were determined from double 
stranded plasmid DNA templates using the Sequenase system 
(United States Biochemical) as instructed by the 
manufacturer. This system uses a modification of the 
Sanger method of sequencing DNA by enzymatic labelling of 
newly synthesized DNA with (a35S] dATP and di-
deoxynucleotide chain termination (92). Plasmid DNA used 
in determining the primary wild type pLV22a sequence was 
prepared by Qiagen affinity column (Qiagen) or CsCl 
purification; mini-prep DNA was also used when sequencing 
mutants. 
Sequencing reactions were electrophoresed in 6% Long 
Ranger gel (FMC Bioproducts, Inc.) in 1.2x TBE (10.7 mM 
Tris base, 10.7 mM boric acid, 0.24 mM EDTA, pH 8.0), with 
an 0.6X TBE (5.3 mM Tris base, 5.3 mM boric acid, 0.12 mM 
EDTA, pH 8.0) running buffer and running temperature of 
47° c. An IBI (International Biotechnologies, Inc.) model 
STS-45 sequencer was used. DNA sequence ladders were 
visualized by placing the dried gel on Kodak X-OMAT AR 
film, generally for 36-48 h. 
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By running a set of sequencing reactions for both 1.5 
hand 4.0 hon the same gel, and then splicing the 
sequence obtained from both, we were able to regularly 
generate 300-350 bp of sequence per gel. 
To sequence the pLV22a mobilization region, 
oligonucleotide primers directed outward from both ends of 
TnlOOO were used: 5 1 -TCAATAAGTTATACCAT-3' (gamma) and 5 1 -
GAATTATCTCCTTAACG-3' (delta). Other primers, 17-20 bases 
in size, were synthesized as needed to fill gaps and 
obtain the complementary DNA sequence. 
32P-labeled DNA Probes 
Supercoiled plasmid DNA, or DNA fragments previously 
agarose gel-purified, were labeled with [~32P] dATP using 
the stratagene Prime-It II random-prime labeling system as 
recommended by the manufacturer. Unincorporated 
nucleotides were separated from labeled probe DNA using a 
G-50 Sephadex spin column (Boerhinger-Mannheim). 
southern Blot Analysis 
DNA-DNA hybridization analysis was carried out using 
a modification of the method of Southern (111). DNA 
fragments to be analyzed were first separated by agarose 
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gel electrophoresis. The DNA was then depurinated by 
washing the gel slab in 0.25 M HCl for -5 min at R.T. with 
gentle agitation, denatured by washing in 0.4 M NaOH and 
0.6 M NaCl for 30 min at R.T. with gentle agitation, and 
then neutralized by washing in 0.5 M Tris pH 7.5 and 1.5 M 
NaCl for 30 min at R.T. with gentle agitation. The DNA 
was then transferred by capillary blotting or vacuum 
transfer to a Genescreen Plus (DuPont) nylon membrane with 
l0X SSC (1.5 M NaCl and 0.15 M trisodium citrate pH 7.0). 
The membrane was then washed in 0.4 M NaOH for 1 min at 
R.T. followed by a 1 m wash at R.T. with 0.2 M Tris pH 7.5 
and 2X SSC (0.3 M NaCl and 0.03 M trisodium citrate pH 
7.0). The filter was then dried, and placed in a glass 
rotator tube (Robbins Scientific), wetted with 2X SSC, and 
pre-hybridized with 5 ml of hybridization solution (0.9 M 
NaCl, 0.09 M trisodium citrate pH 7.0, 1% (w/v) sodium 
dodecyl sulfate, 100 µg/ml denatured salmon sperm DNA, 
0.2% (w/v) Ficoll, 0.2% (w/v) polyvinylpyrolidine and 0.2% 
(w/v) bovine serum albumin Fraction V) for 1 hat 65° c. 
32P-labeled DNA probe was then added to a concentration of 
-1 X 106 dpm/ml, and the filter incubated 4 h to 18 hat 
65° c with slow rotation. The membrane was then washed 
twice with 2X SSC for 5 min at R.T. twice with warm 2X SSC 
and 1% (w/v) sodium dodecyl sulfate for 30 min at 65° c, 
and twice with 0.lX SSC (0.015 M NaCl and 0.0015 M 
trisodium citrate pH 7.0) for 30 min at R.T. The membrane 
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was then placed on Kodak X-OMAT AR film, generally for 18-
20 h. 
Polymerase chain Reaction (PCB) Amplification of the 
pLv22a oriT 
The ori T of pLV22a was cloned using a Perkin-Elmer 
thermocycler and Core Reagent kit as recommended by the 
manufacturer. 36 amplification cycles, a 55° C annealing 
temperature and a 30 sec elongation time were used. A 347 
bp product was generated using the primer pair: 5'-
GCAAGAAGTGTCCTTGTCGG-31 and 3 1-CTCTTGGCCCGTGATTAATG-5 1• A 
437 bp product was generated using the primer pair: 
5-'GCAAGAAGTGTCCTTGTCGG-3 1 and 3'-GTCATGCTGGAGCGGTTTCTC-
51. The PCR products were first cloned into the PCR 
product cloning site of the pGEM-T vector (Promega). The 
products were then cut out with Sall and SphI restriction 
endonucleases, and ligated to the 4.1 kb SalI/SphI 
pACYC184 fragment. The final plasmids, containing the 347 
bp and the 437 bp PCR products, respectively, were 
designated pTJ347 and pTJ437. The products were verified 
by DNA sequencing. 
CHAPTER 4 
RESULTS 
Description of the Transfer Mechanisms of the B, tragilis 
strain Lv22 
LV22 is a clinically isolated strain of B. fragilis. 
An earlier study of LV22 from the laboratory of D.W. Hecht 
determined the following: (~) LV22 contains 2 native 
plasmids and a Tet Element. (Tet Elements are a family of 
closely related, self-transferable chromosomal elements 
that confer tetracycline resistance in Bacteroides 
(74,102)). (~) LV22 is unexpectedly able to restore 
transferability to the normally transfer-deficient (Tra-) 
plasmid pGAT400•BglII. LV22 apparently does so by 
complementing in trans for btgA and btgB, the pBFTMlO 
transfer genes deleted from pGAT400•BglII. (btgA and btgB 
have not been found in LV22 by high-stringency Southern 
hybridization analysis.) We have termed the mechanism 
responsible for transfer of pGAT400•BglII the Trans 
Factor. (k) LV22 can also transfer other Tra- plasmids in 
cis; the mechanism responsible for this has been termed 
the Cis Factor (data not shown). LV22 therefore appears 
to have three distinct mechanisms implicated in 
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conjugative transfer (i.e., transfer by a conjugation-type 
mechanism): a Tet Element, the Trans Factor, and the Cis 
Factor. The original intent of this dissertation project 
was to clone and characterize the LV22 Trans Factor. 
conjugative Transfer of the Trans Factor from B, fragilis 
Lv22 to B, thetaiotaomicron BT4001 
Based upon their different phenotypes, we believed 
that the LV22 Trans and Cis Factors were not genetically 
linked, and could thus be separated to facilitate their 
characterization. Since the Trans Factor restored a 
transferable (Tra+) phenotype to pGAT400•BglII, we 
hypothesized that it might also be capable of self-trans-
fer, and consequently could be segregated from the Cis 
Factor. To test whether the Trans Factor was indeed 
transferable, a filter mating between LV22 and B. 
thetaiotaomicron BT4001 was performed. BT4001 was chosen 
since it contains no known transfer factors (101), and can 
not transfer pGAT400•BglII (data not shown). Direct 
selection for transfer of the Trans Factor was not 
possible, since the Trans Factor is apparently cryptic. 
Based upon the possibility of unlinked co-transfer of the 
Trans Factor and the Tet Element, we instead used 
tetracycline to select for transfer of the LV22 Tet 
Element. 
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In the mating between B. fragilis LV22 and B. 
thetaiotaomicron BT400l, transfer of the Tet Element from 
LV22 to BT4001 occurred at a frequency of 7.2 X 10-6 
transconjugants (those BT4001 recipients that received the 
Tet Element) per input donor. From these, fifty 
tetracycline resistant transconjugants were chosen for 
further characterization, and were designated BT22,1 
through BT22,50 (B. thetaiotaomicron .BT4001 X B. fragilis 
LV.2..2.) • 
Investigation of the Transfer Properties of B, 
thetaiotaomicron strains BT22.1-BT22,so 
our next objective was to determine whether any of 
the B. thetaiotaomicron BT22 transconjugants contained the 
LV22 Trans Factor. In LV22, the Trans Factor has the 
ability to transfer the Tra- plasmid pGAT400•BglII. We 
therefore screened BT22.1-BT22.50 for the presence of the 
Trans Factor by filter mating BT22.l (pGAT400•BglII) -
BT22.50 (pGAT400•BglII) with E.coli HBl0l. 37 of the 50 
BT22 strains transferred pGAT400•BglII to HBl0l at 
frequencies comparable to the transfer of pGAT400•BglII 
from LV22 (data not shown). These data suggested that the 
37 BT22 strains contained the LV22 Trans Factor. However, 
when transconjugant plasmid DNA transferred from the 37 
BT22 strains was analyzed, pGAT400•BglII was frequently 
found to have been altered. This was in direct contrast 
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to LV22, which did not alter pGAT400•BglII upon transfer 
(D.W. Hecht, personal communication). Aval restriction 
endonuclease analysis of pGAT400•BglII from 44 
transconjugants found that while 76% appeared unaltered, 
20% displayed significant deletions of DNA, the majority 
of which involved the loss of a 4.4 kb Aval fragment (fig. 
6). (This fragment contains most of the resident 
transposon of pGAT400•BglII, Tn4400 (fig. 1).) In 
addition to the examples of unaltered or deleted plasmid 
DNA, restriction endonuclease analysis also identified 2 
plasmids that had acquired approximately 1.2 kb of new DNA 
in the 4.4 kb Aval fragment of pGAT400•BglII (fig. 7). 
We concluded from these data that a genetic element 
from LV22 was present in the 37 BT22 strains now capable 
of transferring pGAT4O0•BglII. However, the differential 
phenotypes of pGAT400•BglII transfer observed in LV22 and 
the 37 BT22 strains made it difficult to determine whether 
this element was the Trans Factor. The appearance of 2 
transconjugant plasmids containing 1.2 kb insertions of 
exogenous DNA was nonetheless considered significant, 
since we hypothesized that the insertions might contain 
transfer regions that were responsible for the plasmid's 
Tra+ phenotype. We thus decided to analyze the 2 insert-
bearing plasmids further, and named them pTJ47-1 and 
pTJ47-3. 
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A. 1 2 3 4 5 6 7 8 9 10 11 12 1314 15 16 
6.9kb ~ 
4.4 ~ 
2.8 ~ 
1.1 ~ 
B. 
6.9kb ~ 
4.4 ~ 
2.8 ~ 
1.1 ~ 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
Fig. 6. AvaI restriction digestion patterns of B. thetaiotaomicron 
BT22.1-BT22.50 (pGAT400de1taBglII) XE. coli HB101 transconjugant 
plasmids. Gel~: lanes 1-13, AvaI digested transconjugant plasmids; 
lane 14, AvaI digested pGAT400de1taBglII; lane 15, undigested 
pGAT400de1taBglII; lane 16, 1 kb ladder. Gel~: lane 1, 1 kb ladder; 
lane 2, undigested pGAT400de1taBglII; lane 3, AvaI digested 
pGAT400de1taBglII; lanes 4-16, AvaI digested transconjugant plasmids. 
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A. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
6.9kb -
4.4 -
2.8 ----. 
1.1 -
B. 
6.9 kb 
-5.6 
-4.4 
-2.8 
-
1.1 
-
1 2 3 4 5 6 7 8 9 10 11 12 
Fig. 7. AvaI restriction digestion patterns of pTJ47-1 and pTJ47-3. 
Gel~: lane 1, 1 kb ladder; lane 2, undigested pGAT400de1taBglII; 
lane 3, AvaI digested pGAT400de1taBglII; lanes 4-16, AvaI digested 
transconjugant plasmids. Gel~: lane 1, 1 kb ladder; lane 2, 
undigested pGAT400de1taBglII; lane 3, AvaI digested pGAT400de1taBglII; 
lanes 4-12, AvaI digested transconjugant plasmids. Lane 8 contains 
pTJ47-1; lane 9 contains pTJ47-3. 
Initial Analysis of the Exogenous DNA of pTJ47-1 and 
pTJ47-3 
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The first step in the characterization of pTJ47-1 and 
pTJ47-3 was to determine the locations of the new DNA 
within the parental plasmid, pGAT400•BglII, using 
restriction endonuclease mapping. The exogenous DNA of 
pTJ47-1 and pTJ47-3 was initially positioned within a 
region of pGAT400•BglII containing a resident transposon, 
Tn4400. Tn4400 consists of a core region, encoding 
antibiotic resistance determinants, and identical IS 
elements, IS4400 1eft and IS4400right, which flank the core in 
a directly repeated orientation. The IS elements are 
responsible for transposition of the transposon, and both 
the external and internal ends of the IS elements are 
functional in this regard (81). Additional restriction 
endonuclease analysis found that while IS4400 left and 
IS4400right were intact, the 3. O kb core region of Tn4400 
had been deleted (fig. 8). DNA sequencing of the 
junctions between the IS ends and the exogenous DNA 
confirmed that the core of Tn4400, up to the ends of 
IS4400 1eft and IS4400rightt had been replaced with new DNA 
(data not shown). Consequently, pTJ47-1 and pTJ47-3 did 
not carry simple 1.2 kb insertions as originally thought, 
but instead had simultaneously lost 3.0 kb of Tn4400 core 
DNA and acquired 4.2 kb of new DNA in its place. 
A. &~ Tn4400 & 
E A A E A H H C BT E A EV H E 
pDG5 pBFTM10 1 kb 
B. E A SC HC EV S3 N BS E A 
11  I I I I I I I I I 11 
1::::::::1::::::::::::::::::::!!:~ New DNA I . "I -::::::::::::::::::::L::::::: 0.5kb 
c. E A EV S3 N BS SC HC E A 
11 1 I I I I I I I I I 11 
Fig. 8. Maps of (A.) pGAT400 delta BglII, (~) pTJ47-1 and (,S_) pTJ47-3. Restriction enzymes are 
as follows:~, Aval; BS, BstXI; BT, BstUI; ~, ClaI; ~, EcoRI; EV, EcoRV; ~, HindIII; HC, HincII; 
~, NsiI; S3, Sau3AI; and SC, SacI. Stippled boxes at the left and right ends of Tn4400 are 
IS4400left and IS4400right, respectively. Section A: linear map of pGAT400 delta BglII, the 
parental plasmid of pTJ47-1 and pTJ47-3. The dotted box is expanded in Section B. Cc denotes 
clindamycin resistance determinant. Section B: linear maps of pTJ47-1 and pTJ47-3, indicating the 
regions of new DNA within pGAT400 delta BglII, and showing the accompanying new restriction sites. 
Dotted line denotes 1.8 kb SacI-EcoRV probe fragment. // denotes truncated DNA. ~ 
- \0 
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Endonuclease restriction mapping of the exogenous DNA 
in pTJ47-1 and pTJ47-3 identified similar BstXI, EcoRV, 
HincII, NsiI, SacI and Sau3AI restriction endonuclease 
sites in the new regions of the plasmids, although the 
sites in pTJ47-1 appear to be shifted with respect to the 
sites in pTJ47-3 (fig. 8). These data suggested that the 
exogenous DNA of pTJ47-1 and pTJ47-3 was an identical, 4.2 
kb plasmid. 
Determination of the origin of the Exogenous DNA of 
pTJ47-1 and pTJ47-3 
our next objective was to learn if the exogenous DNA 
of pTJ47-1 and pTJ47-3 was a 4.2 kb plasmid as we 
suspected, and to determine the origin of this DNA. 
pTJ47-1 and pTJ47-3 were formed when their parental 
plasmid, pGAT400•BglII, was transferred from B. 
thetaiotaomicron BT22.47 to E.coli HBlOl, and acquired 
new DNA in the process. BT22.47 in turn is a result of a 
mating between B. fragilis LV22 and B. thetaiotaomicron 
BT4001, and contains DNA from both parents. Thus, the new 
DNA of pTJ47-1 and pTJ47-3 potentially had its origins in 
LV22, BT4001, or both strains. We utilized high-
stringency Southern hybridization analysis to determine 
the source and nature of the exogenous DNA. First, the 
5.3 kb restriction endonuclease Aval fragment of pTJ47-1, 
containing the exogenous DNA and IS4400 1eft (fig. 8), was 
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labeled with [ 32P] and used to probe whole-cell LV22 and 
BT4001 DNA digested with BamHI/SmaI, EcoRI, EcoRV and 
HindIII restriction endonucleases. The 5.4 kb AvaI 
fragment of pTJ47-1 hybridized with LV22 DNA, while no 
homology was exhibited with BT4001, indicating that the 
exogenous DNA was derived from LV22 alone (fig. 9). 
Furthermore, the relatively high intensity of the 
autoradiograph bands supported our premise that the 
exogenous DNA was one of two plasmids native to LV22. (A 
similar-sized plasmid is also present in BT22.47, but not 
BT4001, as seen in EtBr-stained agarose gels (data not 
shown).) A second Southern hybridization was then 
performed to determine the relationship between the 
exogenous DNA of pTJ47-1 and pTJ47-3, and the plasmids 
present in LV22 and BT22.47. Plasmids from B. fragilis 
LV22, B. thetaiotaomicron BT4001 and B. thetaiotaomicron 
BT22.47, and plasmids pTJinsla and pTJins3a, were digested 
with HincII/EcoRV. (pTJinsla and pTJins3a contain the 
exogenous DNA fragments of pTJ47-1 and pTJ47-3, 
respectively (Figs. 3 and 4).) The cloning vector of 
pTJinsla and pTJins3a, pGEM7Zf(+), was digested with PvuI 
and included as a negative control. The resulting digests 
were separated by agarose gel electrophoresis, transferred 
to nylon membranes, and then probed with a [ 32P]-labeled 
1.8 kb SacI/EcoRV fragment of pTJ47-1. This fragment is 
internal to the exogenous DNA of pTJ47-1, and overlaps the 
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4.2kb-.. 
undig. ····► 
Fig. 9. Southern hybridization autoradiograph of B. fragilis LV22 
and B. thetaiotaomicron BT4001 total DNA probed with the 5.4 kb AvaI 
fragment of pTJ47-1. Lane loading: 1-2, EcoRI digested LV22 DNA; 
i, EcoRI digested BT4001 DNA; 4-5, EcoRV digested LV22 DNA;~, 
EcoRV digested BT4001 DNA; 7-8, BamHI/SmaI digested LV22 DNA;~, 
BamHI/SmaI digested BT4001 DNA; 10-11, HinDIII digested LV22 DNA; 
12, HinDIII digested BT4001 DNA. undig. represents probable 
undigested DNA. Autoradiograph was exposed for 2 d. 
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internal HincII/EcoRV fragments of the exogenous DNA in 
both pTJ47-1 and pTJ47-3 (fig. 8). The probe hybridized 
to 1.2 kb and 3.0 kb HincII/EcoRV plasmid fragments of 
LV22 and BT22.47, to the 1.2 kb HincII/EcoRV fragment 
internal to the exogenous DNA of pTJ47-1, and to the 3.0 
kb HincII/EcoRV fragment internal to the exogenous DNA of 
pTJ47-3. (The probe also hybridized to vector/insert 
junction fragments from pTJ47-1 and pTJ47-3.) No homology 
was detected with BT4001 DNA, nor with the cloning vector, 
pGEM7Zf(+) (fig. 10). The results of this study, together 
with restriction analysis data, indicate that pTJ47-1, 
pTJ47-3, LV22 and BT22.47 all contain a related, and 
probably identical, 4.2 kb plasmid that we have designated 
pLV22a. 
These data indicated that pLV22a had transferred from 
B. fragilis LV22 to B. thetaiotaomicron BT4001 during the 
original mating that produced B. thetaiotaomicron BT22.47. 
We hypothesized that pLV22a might contain an active 
transfer region, and was therefore responsible for its own 
transfer into BT4001. Our next set of experiments were 
therefore designed to investigate what transfer 
properties, if any, were possessed by pLV22a. 
7.0kb 
5.2 
undig. 
3.0 
1.2 
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Fig. 10. Southern hybridization autoradiograph of B. fragilis LV22, 
B. thetaiotaomicron BT4001, and B. thetaiotaomicron BT22.47 
plasmids probed with the 1.8 kb SacI/EcoRV fragment of pTJ47-1. Lane 
loading:!, PvuII digested pGEM7Zf(+); ~, EcoRV/HincII digested 
pTJinsla; 1, EcoRV/HincII digested pTJins3a; !, EcoRV/HincII 
digested plasmid contents of LV22; ~, EcoRV/HincII digested plasmid 
contents of BT4001; ~ EcoRV/HincII digested plasmid contents of 
BT22.47. undig. represents probable undigested plasmid DNA. 
Autoradiograph was exposed for 30 rn. 
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Investigation of the Transfer Properties of pLV22a While 
in E, coli 
Our next line of inquiry attempted to define what 
transfer capabilities were possessed by pLV22a, and to 
thus confirm that pLV22a was responsible for the Tra+ 
phenotype of pTJ47-1 and pTJ47-3. pLV22a is a B. fragilis 
plasmid, and accordingly we predicted that it would be 
transferable from that species. However, pTJ47-1 and 
pTJ47-3 could not be tested for transfer from a B. 
fragilis host, since they carried no antibiotic resistance 
genes expressed in Bacteroides. (The clindamycin 
resistance gene of their parental plasmid, pGAT400•BglII, 
had been deleted during the formation of pTJ47-1 and 
pTJ47-3. pTJ47-1 and pTJ47-3 thus could not be detected 
by antibiotic selection in B. fragilis. See Initial 
Analysis of the Exogenous DNA of pTJ47-1 and pTJ47-3, 
Chapter 4.) We therefore decided to initially test pLV22a 
for transfer in E.coli. This was not without precedent. 
The Bacteroides plasmids pBFTMl0 and pBS-51, and the 
Bacteroides transposon Tn4399, cannot transfer from E. 
coli unassisted. However, they can all transfer from E. 
coli when co-resident with R751, a conjugal broad-host-
range IncPB plasmid (i.e., they are mobilized when co-
resident with R751; Mob+) (59,104,117). 
To test whether pTJ47-1 and pTJ47-3 are mobilized 
when co-resident with R751, E.coli HBl0l (R751) (pTJ47-1) 
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and HBlOl (R751) (pTJ47-3) were filter mated with E.coli 
DW1030. pTJ47-1 and pTJ47-3 were mobilized at frequencies 
similar to that of pBFTMlO (in pGAT400), when co-resident 
with R751 (table 3). This was in direct contrast to the 
parental plasmid of pTJ47-1 and pTJ47-3, pGAT400•BglII, 
which was not mobilized (Mob-). Thus, the mobilization of 
pTJ47-1 and pTJ47-3 is directly attributable to pLV22a. 
However, pLV22a, like pBFTMlO, pBS-51, and Tn4399, 
requires the co-residence of R751 for mobilization in E. 
coli. 
Table 3.--R751 mobilization of pLV22a derivatives in E.coli 
Plasmids 
pGAT400 
pGAT400t.BglII 
pACYC184 
pTJ47-1 
pTJ47-3 
pTJSa 
pTJ6 
pTJ6XB 
Presence of pLV22a Mean frequency of 
in cis mobilizationa 
(+/--) (± SEM) 
+ 
+ 
+ 
+ 
+ 
2.9 (±1.2) X 10~ 
< 1.0 
< 1.0 
3. 7 (±1.9) X 10-3 
3.9 (±0.6) X 10~ 
3.2 (±0.4) X 10~ 
1. 0 (±0. 5) X 10-2 
7.5 (±2.8) X 10~ 
Notes: Plasmids were mobilized from E.coli HB101 containing 
R751 to E.coli DW1030. 
a Mobilization frequency is defined as the number of plasmid 
transconjugants / number of R751 transconjugants in the same 
mating (N=3). 1 X 10-5 defines the limit of detection. 
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The Mobilization of pLV22a Independent of pGAT400•BglII 
We next wanted to determine whether pLV22a contained 
a mobilization region capable of functioning independently 
of pGAT400•BglII. To investigate this, the 5.3 kb EcoRI 
restriction endonuclease fragment from pTJ47-1, containing 
pLV22a, was ligated into the Mob- cloning vector pACYC184 
to give pTJ5a (fig. 3). Similarly, the 5.3 kb EcoRI 
restriction endonuclease fragment from pTJ47-3, containing 
pLV22a, was ligated into pACYC184 to give pTJ6 (fig. 3). 
pTJ5a and pTJ6 were then tested for mobilization when co-
resident with R751 by mating E. coli HBlOl (R751) (pTJ5a) 
and HBlOl (R751) (pTJ6) with E.coli DW1030. pTJ5a and 
pTJ6 were both mobilized at levels comparable to the 
pLV22a::pGAT400•BglII fusion plasmids pTJ47-1 and pTJ47-3 
(table 3). These results indicate that pLV22a provides 
the functions required for its mobilization, and can thus 
operate independently of pGAT400•BglII in this regard. 
comparison of pLv22a to the Transfer Region of pBFTMlo 
We wished to learn whether pLV22a was related to 
pBFTMlO, the only other Bacteroides transferable plasmid 
characterized at the time (41). We used a study based 
upon high-stringency Southern hybridization analysis to 
determine whether pLV22a possessed homology to the pBFTMlO 
origin of transfer (oriT), or its transfer genes, btgA and 
btgB. pTJinsla and pTJins3a, containing pLV22a from 
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pTJ47-1 and pTJ47-3 respectively, were digested with EcoRI 
restriction endonuclease, the resulting fragments were 
separated by agarose gel electrophoresis and then 
transferred to 3 nylon membranes. These membranes were 
then probed with [ 32PJ-labeled plasmids containing either 
the pBFTMl0 oriT (pJA-7ZT), btgA (pJA-lla), or btgB 
(pJA-223B). No hybridization was detected between any of 
these probes and the 5.3 kb EcoRI restriction fragments of 
pTJinsla and pTJinsJa, containing pLV22a (data not shown). 
We therefore concluded from these data that no significant 
homology exists between the mobilization region of pLV22a 
and the transfer region of pBFTMl0. 
We had now isolated a novel B. fragilis transfer 
factor, pLV22a, for which we had direct evidence of 
mobilization in E.coli, and transfer in B. fragilis. 
Because of this, we decided to shift the focus of our 
study from the LV22 Trans Factor to pLV22a. 
Localization of the pLV22a Mobilization Region by Tn1000 
Random Insertion Mutagenesis 
Our next objective was to identify the region of 
pLV22a required for mobilization in E.coli when co-
resident with R751. We used the transposon TnlOOO to 
mutagenize pLV22a, thereby inactivating the region(s) of 
pLV22a necessary for mobilization. The target plasmid, 
pTJ5a, was mutagenized by mating E.coli DWl0J0 
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(F'lac) (pTJ5a) with E.coli HBl0l. Of 50 TnlOOO insertion 
mutations generated, 37 were restriction endonuclease 
mapped to the pLV22a portion of pTJ5a (fig. 11). Each of 
the 37 mutants was then further tested for mobilization 
from E.coli HBl0l (R751). Ten mutants, pAC67, pAC38, 
pAC39, pAC7, pAC49, pAC18, pAC20, pACll, pAC47, and pAC42 
were found to be Mob- (data not shown). Restriction 
endonuclease mapping revealed that the mutations of the 10 
Mob- plasmids were located in a contiguous 1.5 kb region 
of pLV22a (fig. 11). The other 27 mutants remained Mob+, 
and mapped to the remaining 2.7 kb of pLV22a. 
To verify that the 1.5 kb region of pLV22a identified 
by TnlOOO mutagenesis was sufficient for mobilization, the 
region was sub-cloned, (along with 0.2 kb of upstream DNA) 
into the Mob- cloning vector pACYC184, giving pTJ6XB. 
pTJ6XB was then tested for mobilization when co-resident 
with R751 by filter mating E.coli HBl0l (R751) (pTJ6XB) 
with DW1030. As predicted, mobilization of pTJ6XB was 
comparable to the parental plasmid pTJ6 (table 3). These 
results indicate that the 1.5 kb region of pLV22a 
identified by TnlOOO mutagenesis is sufficient for 
mobilization from E.coli, when co-resident with R751. 
Transfer of pLv22a from B, tragilis 
We hypothesized that pLV22a, a B. fragilis plasmid, 
would be transferable in B. fragilis. To test this 
18 42 
39 20 47 
, , 1!!!/!!!ii!ii!!!<iiiiiiiiiii/l] ,671381 I 7 I 49 ]11[ 28 I O • • I I I h JI[ d I -~[I I tlll1i" A SC EV E 
0.25kb 
Fig. 11. Map of TnlOOO insertions in pLV22a, as found in pTJSa. Heavy solid line denotes pLV22a DNA. 
// denotes truncation of vector DNA. Stippled box represents IS4400left. Restriction sites are as 
follows:~, Aval;~, EcoRI; EV, EcoRV; and SC, SacI. Open symbols indicate mobilization-deficient 
TnlOOO insertions; closed symbols represent mobilization-proficient insertions. Numbers above circles 
indicate mutant numbers (see text). 
--.J 
0 
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hypothesis, a 3.3 kb Sau3AI/BamHI fragment containing the 
pLV22a mobilization region was cloned into the unique 
BglII site of pGAT400•ori, giving pTJlO (fig. 5). 
{pGAT400•ori is a derivative of the E. coli-Bacteroides 
shuttle plasmid pGAT400, in which the pBFTMlO transfer 
region has been deleted. See Plasmid Constructions, 
Chapter 3.) Transfer of pTJlO in B. fragilis would be 
attributable to the presence of pLV22a in cis, since 
pGAT400•ori is transfer-deficient. pTJlO was tested for 
transfer in a mating between B. fragilis TM4000 (pTJlO) 
and E. coli HBlOl. TM4000 was selected as the donor 
because it is a well-characterized laboratory reference 
strain that is devoid of any detectable transfer factors. 
pTJlO was determined to be transferable from TM4000 to E. 
coli HBlOl at 7.1 X 10-9 transconjugants/input donor, a 
frequency comparable to that of pBFTMlO in pGAT400 (table 
4). These data indicate that the pLV22a mobilization 
region functions at a low but measurable frequency in B. 
fragilis as well as in E.coli. 
It has been previously shown that Bacteroides strains 
that contain Tet Elements are able to increase the 
transfer of co-resident plasmids such as pBFTMlO and 
pBS-51 (117). Tet Elements are Bacteroides-specific, 
chromosomal elements that carry tetracycline, and 
sometimes clindamycin, resistance genes, and are capable 
Table 4.--pLV22a transfer from B. fragilis 
Mean frequency of transfera 
(± SEM) 
From B. fragilis From B. fragilis TM4.23 
Plasmids TM4000 
pGAT400 4.5 (±0.5) X 10-9 8.3 (±4. 9) X 10-5 
pGAT400t.ori <1.0 X 10-9 <1.0 X 10-9 
pTJl0 7.1 (±3.0) X 10-9 1.5 (±1.1) X 10-5 
Notes: Plasmids were transferred from B. fragilis to E. coli HBl0l. 
72 
a Transfer frequency is defined as the number of 
transconjugants/input donor in the same mating (N=3). lXl0-9 defines 
the limit of detection. 
of conjugation-type transfer (4,102). The mechanism by 
which plasmids use the Tet Element transfer system to 
increase the efficiency of their own transfer is not 
understood, but is at least superficially similar to the 
mobilization of pBFTMlO and pB8-51 by R751 in E. coli. 
(See Horizontal Gene Transfer Factors, Chapter 2.) 
To determine whether pLV22a transfer would be 
enhanced by a co-resident Tet Element, TM4.23 (pTJlO) was 
mated with E. coli HBlOl. (TM4.23 is a Tet Element+ 
isogeneic derivative of TM4000.) TM4.23 (pTJlO) was pre-
treated with lµg/ml of tetracycline 2 h prior to mating, 
since tetracycline increases the transfer of both Tet 
Elements and co-resident plasmids (104,117). pTJlO was 
found to transfer to HBlOl at a frequency of 1.5 X 10-s 
transconjugants/input donor, which represents a 3.5 order 
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of magnitude increase over its transfer frequency from the 
Tet Element- isogeneic strain TM4000 (table 4). These 
results demonstrate that pLV22a transfer in B. fragilis, 
like pBFTMl0 in pGAT400, is substantially enhanced by the 
co-residence of a Tet Element (table 4). 
DNA Nucleotide sequence of the pLV22a Mobilization Region 
Our next course of experiments were designed to 
identify the pLV22a genes required for mobilization in E. 
coli. We began by sequencing the pLV22a mobilization 
region enzymatically by the method of Sanger. The DNA 
sequences of both top and bottom strands were determined 
using the following strategy: (a} a set of pTJ5a mutants 
containing TnlOOO transposon insertions located throughout 
the mobilization region was selected. (b) Outward-facing 
DNA oligonucleotide primers homologous to the ends of 
TnlOOO were used to generate sequence data from each 
mutant. (~) Additional oligonucleotide primers were used 
to fill gaps in the DNA sequence that occurred due to 
distantly spaced insertion mutations (fig. 12). 
Figure 
12 
© 
1 GCGGTTGGCGTGGATGTATTCCCATGCGGCATGTGTATATATAGCAAGAA 
51 GTGTCCTTGTCGGACAATTCTTGCTTTTCTCGCTTTGCTCAAAAAGATTT 
0 
101 TAAGATTACCTTTGTGGCATGGAACTAAGACGGAACGAAAAGATTACATT 
mbpA M E L R R N E K I T F 
151 CCGGTGTACCGAACTTGAAAAGGACGCACTTGCGGAGCAGGCAGCCCGGT 
R C T E L E K D A L A E Q A A R 
----------> IRl < 201 GCAGTCTAAGCGTATCGGAATACTGCCGGAGTTTGTCCCTTGGGGGGCGC 
C S L S V S E Y C R S L S L G G R 
---------- --------> IR2 <--------251 CCAAGGGAGAGGTACACCGAGGAGGAACGGCAGCTTCTCCGGGACATAGC 
P R E R Y T E E E R Q L L R D I A 
T67 
301 CCAGTTGAAAGGAACGCTCCAACGGCTGAACAACTACTTCGGTGGTCGCC Q L K G T L Q R L N N Y F G G R 
® 
351 AGTACCGGGAAGTGTTCGAGGAGAACCGGGCACTAATTACAGAGCTCAAA 
Q Y R E V F E E N R A L I T E L K 
401 AAAATACTCTCACGATGATAGGGAAAGGGAAAAGCATATCACATGGTGTG 
K I L S R * 
mbpB M I G K G K S I S H G V 
38T@ 
451 GCGGCATTGGAGTACGACCTCGCCAAAGAGATAAACGGGCAGGCAGTAGC 
A A L E Y D L A K E I N G Q A V A 
39T 
501 CACCGAGATAGCCCGGCATGAACTTTATGGGTGTACTGGTGCGGAAATGG 
T E I A R H E L Y G C T G A E M 
551 TGCAGGAAATGAAACCGTATCACATTGATTTTCCGAACGTAAAAAACAAC 
V Q E M K P Y H I D F P N V K N N 
601 TGCCTACGTTTCGAGGTCAGCCCCTCGATAGAGGAAAGCGCCACCTTTAC 
C L R F E V S P S I E E S A T F T 
651 GGATGCGGACTGGGCGGAACTTGGTAACGACTTCATGCAGCGCATGGGGT 
D A D W A E L G N D F M Q R M G 
701 TGGCGAACCACCAGTACATCATCATCCGGCACAGCGGTACGGAGAGCAAG 
L A N H Q Y I I I R H S G T E S K 
751 AAAGAGCAAGCCCACCTGCACATACTGGCAAACCGGGTTTCCCTTTCCGG 
K E Q A H L H I L A N R V S L S G 
801 GGAACTGTACCGGGACAACTGGATAGGGAAAAAGGCAACGGAAGCCGCCA 
E L Y R D N W I G K K A T E A A 
851 ATGCCATAGCCAAGGAACGGAACTTTGTACAGTCGCAGGACATTGGCAAA 
N A I A K E R N F V Q S Q D I G K 
7T 
901 GTCAACAAAGCGGAAATCAAGGAAGCCATGGACGGCGTATTGAAGAAGAT 
V N K A E I K E A M D G V L K K M 
951 GCAGGGCTTTGACTTTACCAAATTCAAGGAAGAACTTGGTAAGAGAGGTT 
Q G F D F T K F K E E L G K R G 
1001 TTAAAGTCCGGGAAGCCAGGGCAAGCACCGGGAAACTTAACGGCTACTAT 
F K V R E A R A S T G K L N G Y Y 
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1051 
1101 
1151 
1201 
1251 
1301 
1351 
1401 
1451 
1501 
1551 
1601 
1651 
GTCACAGCCCGAAGCGGTACGGAGTATAAGGCAAGCGAGATAGGGAAAGG 
V T A R S G T E Y K A S E I G K G 
CTACACTCTCGCCCATATCGAGCGGACACAAAGCAAACTGAAGTGCAACT 
Y T L A H I E R T Q S K L K C N 
CAATGAACATATCTCATGGAAACAAACTCACACCCGGAAGCGGCAGCTTC 
S M N I S H G N K L T P G S G S F 
mbpC M E T N S H P E A A A S 
CAACGTTAAGCAGGGACAGTACAGCCCCCGGAAAAGAAAAGATACAACGC 
G R * 
N V K Q G Q Y S P R K R K D T T 
49T 
CAAGGGTAAACCCGCAGCTTGCGGTAGAACTGGTGTATCAAGAACTAAAG 
P R V N P Q L A V E L V Y Q E L K 
CGTGTTGAAGTCTATACGAAGCGCATAGAGGACGCAACAGCCCGAAAGGT 
R V E V Y T K R I E D A T A R K V 
ACAAATAGACGGGAAAAGCCTTGAAAGTGCCGAAAATCGCCTAAAAAACG 
Q I D G K S L E S A E N R L K N 
TGTTGGCGGACTTTGAACGGCAGGGGTACAGAATGAAAAACGGCGGTTAT 
V L A D F E R Q G Y R M K N G G Y 
20T T18 
GTGGACAAACGAATTTCGTTCTACTCAATCCTTTGTGCTGTTATCTCCCT 
V D K R I S F Y S I L C A V I S L 
ATTGTTCGCTTGTTTCATGTGCTATCTTTGGACGGATGCAGCCAAAGACC 
L F A C F M C Y L W T D A A K D 
llT T42/47 
GGGACAACTACAAGCAGTATTATGAATACTACCAAGAGCAGGCAAGGGAA 
R D N Y K Q Y Y E Y Y Q E Q A R E 
<I> 28T 
CAAAAGGGGAATAAATAAACATCTAACTTTACGAATTATGGGAACAACGG 
Q K G N K * 
AACACGAAGAACCCCGGTTCTTCTTCATACTGAACAAGGGTGCGAAGTCC 
1701 GGCGGCGAAATCACCCATGCCGTCCTAAACGGTAGTATCG 1740 
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Fig. 12. DNA nucleotide (top line) and deduced protein (bottom line) 
sequences of the pLV22a mobilization region. T denotes TnlOOO 
insertion sites, given by number (see text). Inverted repeat 
sequences l.Rl. and lB2. are indicated by horizontal arrows above DNA 
sequence. Q denotes the insertion site of pGAT4006BglII into pLV22a, 
as found in pTJ47-1 (IS4400 1ett ends to the left of nt 101 in pTJ47-1). 
~ denotes the insertion site of pGAT4006BglII into pLV22a, as found 
in pTJ47-3 (IS4400r1ght begins to the right of nt 1608 in pTJ47-3). 
Primers used to generate the PCR products of pTJ347 and pTJ437 start 
at: ill top strand, pTJ347 and pTJ437; ~ bottom strand, pTJ347; ~ 
bottom strand, pTJ437. ~ denotes translational stop codons. 
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computer Analysis of the pLv22a Mobilization Region DNA 
sequence 
The primary DNA structure of the pLV22a mobilization 
region was analyzed for the presence of open reading 
frames (.QR.Es.) with the DNASIS program (version 3.00 for 
IBM compatible personal computers, Hitachi Software 
Engineering co.). Based on methionine start sites, 5 open 
reading frames {ORFs) of greater than 10 kDa were 
identified (fig. 13). orf 1, orf 2 and orf 3 are located 
in the top strand. orf 1 codes for a theoretical protein 
product of 99 amino acids (aa) (11.7 kDa); orf 2 codes for 
a theoretical 264 aa protein {29.4 kDa); and orf 3 codes 
for a theoretical 150 aa protein (17.6 kDa). orf 1 and 
orf 3 are both in the first reading frame of the top 
strand, while orf 2 is in the third reading frame. orf 1 
and orf 2 overlap by 4 bp, while orf 2 and orf 3 overlap 
by 44 bp. The bottom strand of the pLV22a mobilization 
region contains 2 ORFs, orf 4 and orf 5. orf 4 codes for 
a theoretical protein product of 170 aa {18.9 kDa), while 
orf 5 codes for a theoretical protein product of 119 aa 
(13.4 kDa). orf 4 is in the second reading frame of the 
bottom strand, while orf 5 is in third reading frame. orf 
4 and orf 5 overlap by 326 bp. Numerous ORFs less than 10 
kDa in size were also identified (data not shown). 
All 10 of the Mob- TnlOOO insertion mutants of pLV22a 
disrupt one or more of the 5 mobilization region ORFs 
1 3 
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Fig. 13. Major open reading frames of the pLV22a mobilization region. Solid horizontal line 
represents pLV22a mobilization region, as found in pTJ47-1. Stippled box represents the right end of 
IS4400left. f_j_ denotes truncated DNA. Open symbols indicate mobilization-deficient TnlOOO 
insertions, while the closed symbol denotes a mobilization-proficient insertion; numbers correspond 
to mutant number. Nucleotide numbering corresponds to that of pLV22a sequence as found in Figure 12. 
Horizontal arrows numbered 1-5 denote open reading frames of the same number. 
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identified by DNA sequence analysis (fig. 13). Of these 
Mob- mutants, 6 were selected for further study. The 
mutation of pAC67 disrupts orf 1, the mutations of pAC38, 
pAC39 and pAC7 disrupt orf 2, and the mutations of pAC49 
and pAC18 disrupt orf 3. The Mob- phenotypes of these 
mutants indicate that orf 1, orf 2, and orf 3 are required 
for mobilization in E.coli when co-resident with R751. 
The mutation of pAC7 also disrupts orf 4 and orf 5 of the 
bottom strand. Thus, orf 4 and/or orf 5 may also be 
required for mobilization. 
pTJ47-1 and pTJ47-3 were formed when the parental 
plasmid, pGAT400•BglII, became inserted into 2 different 
sites of pLV22a (See Initial Analysis of the Exogenous DNA 
of pTJ47-1 and pTJ47-3, this chapter.) Sequence analysis 
discovered that orf 3 in pTJ47-3 was interrupted 7 
nucleotides upstream of the translational stop codon by 
the insertion of pGAT400•BglII (fig. 12). In pTJ47-1, orf 
3 is intact due to the alternate site of insertion into 
pLV22a. 
Mutations in ort 1, ort 2, and ort 3 can be complemented 
in trans 
Based upon TnlOOO mutagenesis data, we concluded that 
orf 1, orf 2, and orf 3 are all required for mobilization 
in E.coli. We next used complementation analysis to 
demonstrate that orf 1, orf 2, and orf 3 produce trans-
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acting products. Complementation analysis is an in vivo 
procedure that is performed by placing a mutant sequence 
and a wild type sequence, each on a different and 
compatible plasmid, together in a test cell line or 
strain; the strain is then analyzed for a restoration of 
the function that had been lost in the mutant. A 
restoration of function indicates that the wild type 
sequence provided a trans-acting product (e.g., a protein) 
that complemented the product no longer produced in the 
mutant. A refinement of this procedure places 2 different 
mutant sequences together in trans, after which gain of 
function is measured. In this case, a restoration of 
function to the mutants implies that their mutations are 
in different and independently expressed genes, or are in 
genes located within different operons. 
pLV22a Mob- TnlOOO mutants were first tested for the 
restoration of mobility when co-resident with wild-type 
pLV22a (and R751) in trans. E.coli HBlOl (R751) strains, 
containing pB22a (i.e., wild-type pLV22a) and either pAC67 
(i.e., a mutant of orf 1); pAC38, pAC39, pAC7 (i.e., 
mutants of orf 2); pAC49 or pAC18 (i.e., mutants of orf 3) 
were mated with E.coli DW1030 (fig. 13). pAC67, pAC38, 
pAC39, pAC7, pAC49 and pAC18 were all efficiently 
mobilized when wild-type pLV22a was provided in trans 
(table 5). 
Table s--R751 mobilization of TnlOOO insertion mutants in E.coli 
Plasmids 
Wild-type 
pTJSa 
pACYC184 
Mutants of rob.pc 
pAC49 
pAC49 
pAC18 
pAC18 
Mutants of 111QQB 
pAC38 
pAC38 
pAC39 
pAC39 
pAC7 
pAC7 
Mutant of mb.pA 
pAC67 
pAC67 
Presence of 
pLV22a in trans 
(+/--) 
NA 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Mean Frequency of 
Mobilizationa 
(±SEM) 
3.2 (±0.4) 
< 1.0 
< 1.0 
1.0 (± 0.8) X 10~ 
< 1.0 
6. 6 (± 2. 9) X 10-3 
< 1.0 
3.8 (± 1.4) X 10~ 
< 1.0 
9. 0 (± 6. 5) X 10-3 
< 1.0 
6.2 (± 3.0) X 10~ 
< 1.0 
2.7 (± 1.1) X 10~ 
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Notes: Wild type pLV22a was provided in trans, where indicated, as 
part of the plasmid pB22a. Plasmids were mobilized from E.coli 
HB101 containing R751 (and pB22a, as noted) to E. coli DW1030. NA= 
not applicable. 
a Mobilization frequency is defined as the number of plasmid 
transconjugants / number of R751 transconjugants in the same mating 
(N=3). lxl0-5 defines the limit of detection. 
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To ensure that the mutant plasmids had not been 
mobilized by a cis-acting mechanism (e.g., cointegrate 
fusion with the Tra+ plasmid R751 or the Mob+ wild-type 
plasmid pB22a), 5 samples of transconjugant plasmid DNA 
from each mating were analyzed by BamHI restriction 
endonuclease digestion. The mobilized mutant plasmids 
were found to be unaltered in all cases, supporting the 
premise that they had been mobilized in trans (data not 
shown). These results demonstrated that orf 1, orf 2, and 
orf 3 of the pLV22a mobilization region produce trans-
acting products which are required for mobilization in E. 
coli, when co-resident with R751. Consequently, we 
tentatively designated orf 1, orf 2, and orf 3 as mbpA, 
mbpB and mbpC, respectively, for mobilization of a 
Bacteroides ~lasmid. 
We next used complementation analysis to confirm that 
mbpA, mbpB and mbpC produce trans-acting products required 
for pLV22a mobilization, and to determine the genetic 
organization of mbpA, mbpB and mbpC. This experiment used 
a series of pLV22a Mob- Tn1000 insertion mutants cloned 
into both pBR328• (those plasmids with a BR prefix) and 
pACYC184 (those plasmids using an~ prefix): mutation 67 
(pBR67 and pAC67) in mbpA; mutation 38 (pBR38 and pAC38), 
mutation 39 (pBR39 and pAC39) and mutation 7 (pBR7 and 
pAC7) in mbpB; mutation 49 (pBR49 and pAC49) and mutation 
18 (pBR18 and pAC18) in mbpC (fig. 13). E.coli HBlOl 
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(R751) complementation strains containing both a pBR 
mutant plasmid and a pAC mutant plasmid were then mated 
with E.coli DW1030, and the mobilization frequencies of 
the pAC plasmid calculated. The mobilization of a pAC 
plasmid would indicate that its mutation and the mutation 
of its co-resident pBR plasmid were in different, 
independently expressed genes. Conversely, the lack of 
pAC plasmid mobilization would indicate that its mutation 
and that of its co-resident pBR mutant were located in the 
same gene, or in 2 genes forming an operon. 
complementation analysis of mutations in mbpc. The 
coding region of the putative mobilization gene mbpC 
extends from nucleotide (nt) 1166 to nt 1618 in the pLV22a 
mobilization region sequence (fig. 12), and codes for a 
theoretical 17.6 kDa protein. Two Tn1000 insertion 
mutations were generated in mbpC: the mutation of pAC49 
occurs at nt 1279, while that of pAC18 occurs at nt 1498 
(fig. 12). Both pAC49 and pAC18 are Mob-, but can be 
mobilized from E.coli when wild-type pLV22a is present in 
trans (see Mutations in orf 1, orf 2, and orf 3 can be 
Complemented in trans, this chapter). To confirm that 
they disrupt the same gene, both mutations were analyzed 
for complementation by mating E.coli HBlOl 
{R751) {pAC49) (pBR18) and E.coli HBlOl 
(R751) (pAC18) (pBR49) with E.coli DW1030. In these 
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matings, no transfer of the pAC plasmids to DW1030 was 
detected (table 6). The failure of the mutations in pAC49 
and pAC18 to complement one another supports the premise 
that mbpC is a gene whose trans-acting protein product is 
required for pLV22a mobilization when co-resident with 
R751. 
complementation analysis of mutations in mbpB. The 
coding region of the putative mobilization gene mbpB 
extends from nt 415 to nt 1209, and codes for a 
theoretical 29.4 kDa protein (fig. 12). mbpB is 
interrupted by the TnlOOO insertion mutations of 3 
plasmids, pAC38 (nt 478), pAC39 (nt 535) and pAC7 (nt 927) 
(fig. 12). All 3 are Mob-, but can be mobilized when 
wild-type pLV22a is present in trans (see Mutations in orf 
1. ort 2. and ort 3 can be complemented in trans, this 
chapter). To confirm that they disrupt mbpB, these 
mutations were analyzed for complementation by performing 
the following filter matings: E. coli HBl0l 
{R751) (pAC38) (pBR39), HBl0l (R751) {pAC38) (pBR7), HBl0l 
(R751) (pAC39) (pBR38), HB101 (R751) (pAC39) (pBR7), HBl0l 
(R751) (pAC7) {pBR38) and HBl0l (R751) (pAC7) (pBR39) mated 
with E.coli DW1030. In each case, no mobilization of a 
pAC plasmid to DW1030 was observed (table 6). Therefore, 
the mutations of pAC38, pAC39 and pAC7 cannot complement 
one another, demonstrating that the ORF they disrupt, 
84 
Table 6.--complementation analyses of pLV22a Tn1000 mutants in E. 
coli 
Mobilization complementing Mobilized Mean frequency of 
genotype Plasmid a Plasmid a mobilization b 
(± SEM) 
Wild-type 
pTJ5a 3.2 (±0.4) X 10-3 
pACYC184 <1.0 X 10-5 
mbpC (orf 3) 
pBR49 (mbpC-) pAC18 (mbpC-) <1.0 X 10-5 
pBR18 (mbpC-) pAC49 (mbpC-) <1.0 X 10-5 
mbpB (orf 2) 
pBR7 (mbpB-) pAC38 (mbpB-) <1.0 X 10-5 
pBR38 (mbpB-) pAC7 (mbpB-) <1.0 X 10-5 
pBR7 (mbpB-) pAC39 (mbpB-) <1.0 X 10-5 
pBR39 (mbpB-) pAC7 (mbpB-) <1.0 X 10-5 
pBR38 (mbpB-) pAC39 (mbpB-) <1.0 X 10-5 
pBR39 (mbpB-) pAC38 (mbpB-) <1.0 X 10-5 
pBR18 (mbpC-) pAC39 (mbpB-) 2.5 (±1.4) X 10-3 
pBR39 (mbpB-) pAC18 (mbpC-) 4.7 (±2. 0) X 10-3 
mbpA (orf 1) 
pBR67 (mbpA-) pAC39 (mbpB-) 1. 1( ±0.4) X 10-3 
pBR39 (mbpB-) pAC67 (mbpA-) 9.3 (±5.8) X 10-5 
pBR67 (mbpA-) pAC18 (mbpC-) 1.9 (±0.8) X 10-3 
pBR18 (mbpC-) pAC67 (mbpA-) 2.2 (±1.3) X 10-4 
Notes: Plasmids were mobilized from E. coli HBl0l, containing R751 
and a complementing plasmid where indicated, to E. coli DW1030. 
a See figure 13 for insertion mutation sites within mbpA, mbpB, and 
mbpC. (The number of each pBR and pAC plasmid corresponds to the 
mutation contained within each plasmid.) 
b Mobilization frequency is defined as the number of plasmid 
transconjugants / number of R751 transconjugants in the same mating 
(N=3). 1x10-s defines the limit of detection. 
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mbpB, produces a trans-acting product required for pLV22a 
mobilization. 
A Tn1000 insertion mutation in an upstream gene of an 
operon will theoretically stop the expression of 
downstream genes in that operon as well. This effect on 
downstream genes is known as polarity (5). Thus, the 
TnlOOO insertion mutations that disrupt mbpB could also be 
polar on mbpC, if they constitute an operon (fig. 13). To 
determine whether mbpB and mbpC are part of an operon, the 
Tn1000 insertion mutants pAC39 (mbpB) and pAC18 (mbpC) 
were paired with the mutants pBR18 (mbpC) and pBR39 
(mbpB), respectively, in the following matings: E. coli 
HB101 (R751) (pAC39) (pBR18) and HBlOl (R751) (pAC18) (pBR39) 
mated with E.coli DW1030. pBR18 fully complemented 
pAC39, and pBR39 fully complemented pAC18, demonstrating 
that mbpB and mbpC are independently promoted genes, and 
are not part of an operon (table 6). 
complementation analysis of a mutation in mb.pA.. The 
coding region of the putative mobilization gene mbpA 
extends from nt 119 to nt 418, and codes for a theoretical 
11.7 kDa protein (fig. 12). mbpA is interrupted by the 
Tn1000 insertion mutation of pAC67 (nt 317). pAC67 is 
Mob-, but can be mobilized when wild-type pLV22a is 
present in trans (see Mutations in orf 1. ort 2, and orf 3 
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can be complemented in trans, this chapter). since mbpA 
is the only major ORF disturbed by the mutation of pAC67, 
and because it can be complemented by wild-type pLV22a in 
trans, we conclude that mbpA is a gene whose trans-acting 
product is required for pLV22a mobilization. 
To test whether mbpA and mbpB are part of an operon, 
the following E.coli strains were filter-mated with E. 
coli DW1030: HB101 (R751) (pAC67) (pBR39) and HBl0l 
(R751) (pAC39) (pBR67). Similarly, to test whether mbpA and 
mbpC are part of an operon, the following strains were 
also mated with E.coli DW1030: HBl0l (R751) (pAC67) (pBR18) 
and HBl0l (R751) (pAC18) (pBR67). pBR67 (mbpA) was able to 
fully complement the mutants pAC39 (mbpB) and pAC18 
(mbpC). However, in the reverse experiments, pBR39 (mbpB) 
and pBR18 (mbpC) only partially restored mobility to the 
mutant plasmid, pAC67 (mbpA) (table 6). pBR39 and pBR18 
should produce normal levels of MbpA, since their 
mutations are well downstream of mbpA. We therefore 
reasoned that the partial complementation of pAC67 was due 
to the TnlOOO insertion within mbpA of pAC67 itself (see 
following section). We concluded, however, that mbpB and 
mbpC do not form an operon with mbpA, since pBR67 fully 
complemented mutants of mbpB (pAC39) and mbpC (pAClS). 
Localization of a cis-acting Region Reguired for the 
Mobilization of pLV22a 
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Complementation analysis of pAC67, a TnlOOO insertion 
mutant of mbpA, found that while pAC67 could restore 
mobility in trans to mutants of the downstream genes mbpB 
and mbpC, these same mutant plasmids could only partially 
restore mobility to pAC67 (see complementation Analysis of 
a Mutation in mbpA, this chapter). These data were 
somewhat puzzling upon initial examination. However, 
further analysis suggested that the TnlOOO insertion of 
pAC67 not only disrupts the trans-acting component 
required for mobilization, mbpA, but might also interfere 
with a cis-acting component of mobilization, the oriT (for 
more on the oriT, see Horizontal Gene Transfer Factors, 
Chapter 2.) When this region of DNA was analyzed for the 
presence of grouped direct and/or inverted repeats 
(DNASIS, version 3.00, Hitachi Software Engineering Co.), 
we identified 2 sets of adjacent imperfect inverted 
repeats that are 14 bp (nt 234 - nt 260) and 9 bp (nt 267 
- nt 292) in size (fig. 12). Inverted repeats have been 
previously identified in the oriT sequences of several 
transferable plasmids, including pBFTMlO and RP4 
(41,68,126). Their presence within mbpA supported our 
hypothesis that the mutation of pAC67 interferes with a 
cis-acting oriT that is located within the coding region 
of the gene. 
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To test this hypothesis, the pLV22a 1.5 kb 
mobilization region, from which the first 32 bp of the 
mbpA coding region and upstream promoter sequence had been 
deleted (nt 1 - nt 150, fig. 12), was cloned into the Mob-
vector pACYC184. This construct, pTJ12, was then tested 
for mobilization by filter mating E.coli HBlOl 
(R751) (pTJ12) with E.coli DW1030. As expected, pTJ12 was 
found to be Mob-, due to the partial deletion of the 
mobilization gene, mbpA (table 7). 
Table 7.--Complementation analysis of the pLV22a oriT region 
Complementing 
Plasmid 
NA 
pB22a 
None 
pTJS 
pB22a 
pB22a 
Mobilized Plasmid 
pTJGXB 
pACYC184 
pTJ12 
pTJ12 
pTJ347 
pTJ437 
Mean frequency of 
mobilization a 
( ± SEM) 
7.5 (±2.8) X 10~ 
<1.0 
<1.0 
<1.0 
4.1 (±0.S) X 10-3 
9.4 (±2.6) X 10-3 
Notes: Plasmids were mobilized from E.coli HBl0l, containing R751 
and a complementing plasmid, to E.coli DW1030. l':ffi = not applicable. 
a Mobilization frequency is defined as the number of plasmid 
transconjugants / number of R751 transconjugants in the same mating 
(N=3). lXl0~ defines the limit of detection. 
However, when wild-type pLV22a (pTJ8) was provided in 
trans (HBlOl (R751) (pTJ8) (pTJ12) X DW1030) pTJ12 remained 
mobilization-deficient (table 7). Since the mutation of 
pTJ12 could not be complemented by wild-type pLV22a in 
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trans, we concluded that the region deleted in pTJ12 
contains all or part of the cis-acting component required 
for mobilization, the oriT. 
cloning the pLv22a oriT 
We used the polymerase chain reaction (£CE) to clone 
the putative cis-acting oriT of pLV22a. A 347 bp PCR 
fragment (nt 44 - nt 390) and a 437 bp PCR fragment (nt 
44 - nt 480), both containing the putative oriT region, 
were cloned into the Mob- vector pACYC184, creating pTJ347 
and pTJ437, respectively. pTJ347 and pTJ437 were tested 
for mobilization when co-resident with R751 and with wild-
type pLV22a (pB22a) in trans, by mating the following 
strains with E. coli DW1030: E.coli HBl0l 
(R751) (pB22a) (pTJ347) and HBl0l (R751) (pB22a) (pTJ437). In 
these matings, both pTJ347 and pTJ437 were found to be 
fully mobilizable, relative to wild-type pLV22a in pTJ6XB 
(table 7). To ensure that homologous recombination 
between the cloned fragments of pTJ347/pTJ437 and the 
mobilization-proficient pB22a had not occurred, 5 samples 
of transconjugant plasmid DNA from each of these matings 
were analyzed by restriction endonuclease digestion. As 
expected (both HBlOl and DW1030 are recA mutant strains), 
no alterations were observed in the digestion patterns of 
mobilized pTJ347 and pTJ437 (data not shown). These data 
indicated that pTJ347 and pTJ437 were most likely 
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mobilized in trans when co-resident with wild-type pLV22a 
(and R751), and therefore contain the pLV22a oriT. 
CHAPTER 5 
SUMMARY & DISCUSSION 
The objective of this dissertation project was to 
isolate and characterize a novel conjugative (i.e., 
transferable by a conjugation-type mechanism) B. fragilis 
factor. By describing pLV22a and its mobilization region, 
both here and elsewhere (62), this aim has been achieved. 
The experiments performed in the project may be divided 
into 5 principal groups: 
I. The capture of pLV22a by the transfer-deficient 
;Plasmid pGAT400•BglII in an experiment designed 
/ investigate transfer factors present in the B. 
fragilis strain LV22. 
II. The determination that pLV22a possessed a 
mobilization region which functioned in both B. 
fragilis and E.coli. 
to 
III. The localization of the pLV22a mobilization 
region by the use of TnlOOO insertion mutagenesis, 
and the subsequent determination of the mobilization 
region DNA sequence. Computerized analysis of this 
sequence identified 5 major open reading frames 
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(ORFs), all of which were potentially required for 
mobilization in E.coli. 
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IV. The use of complementation analysis to 
demonstrate that the 3 "top strand" ORFs, designated 
mbpA, mbpB and mbpC, produce trans-acting products 
which are required for transfer in E. coli. 
v. The cloning of a cis-acting element located 
within mbpA that is required for transfer in E.coli, 
and which probably represents the pLV22a origin of 
transfer oriT. 
A discussion of the findings from each group of 
experiments follows. 
capture of pLV22a by pGAT400•BglII in B. thetaiotaomicron 
BT22,47 
In a search for novel Bacteroides conjugative 
transfer factors, the Bacteroides-E. coli Tra- shuttle 
plasmid pGAT400•BglII captured a 4.2 kb plasmid, pLV22a, 
in a mating between B. thetaiotaomicron BT22.47 
(pGAT400•BglII) and E.coli HBl0l. From this mating, 2 
transconjugants were found to contain 
pGAT400•BglII::pLV22a fusions, designated pTJ47-1 and 
pTJ47-3. We hypothesized that pTJ47-1 and pTJ47-3 had 
been formed in the donor, BT22.47, and that pLV22a 
conferred transferability to the fusion plasmids, enabling 
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them to transfer to HBlOl. The donor, BT22.47, was itself 
a product of a conjugative mating between a clinical 
isolate, B. fragilis LV22, and a laboratory reference 
strain, B. thetaiotaomicron BT4001. We used high-
stringency Southern hybridization analysis to determine 
that pLV22a was present in BT22.47, and 1 parent, LV22, 
but not in the other parent, BT4001 (fig. 10). The fact 
that pLV22a had transferred from LV22 to BT4001, (giving 
BT22.47), provided additional evidence that the plasmid 
possessed conjugative properties. 
pLV22a was captured by inverse transposition of 
Tn4400, the resident transposon of pGAT400•BglII. Tn4400 
is comprised of a core antibiotic resistance region which 
is flanked by 2 mobile DNA sequences, 1S4400 left and 
IS4400ti~c, in a directly repeated orientation (fig. 1) 
(81). Restriction-endonuclease mapping and DNA sequencing 
of the pLV22a-pGAT400•BglII junctions determined that all 
core Tn4400 DNA internal to IS4400 1eft and IS4400right had 
been replaced by pLV22a DNA. These data indicated that 
pLV22a had been acquired by 1S4400-driven inverse 
transposition events, in which the inward-facing IS ends 
functioned to delete the core DNA and simultaneously 
acquire pLV22a. While Tn4400 inverse transposition in E. 
coli has previously been reported (81), this is the first 
known instance of inverse transposition in Bacteroides. 
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In the mating that produced pTJ47-l and pTJ47-3, 2 
other types of pGAT400•BglII transfer were also noted 
(figs. 6 and 7): (s) transfers resulting in the deletion 
of Tn4400 from pGAT400•BglII, and (h) transfers of 
unaltered pGAT400•BglII. Since both pTJ47-l and pTJ47-3 
have proven to be extremely stable in E.coli, the 
possibility exists that pGAT400•BglII may have in some 
instances been transferred by a Bacteroides factor other 
than pLV22a hypothetically present in the donor, BT22.47. 
Type g products could have been produced if the putative 
BT22.47 transfer factor was integrated into pGAT400•BglII 
by Tn4400, where it directed transfer of the cointegrate 
into E. coli, and was then deleted due to an instability 
of Bacteroides DNA in E. coli. Such instability of 
Bacteroides transfer factors in E.coli has been noted 
elsewhere (102,105). Alternatively, type h products may 
have been the result of pGAT400•BglII transfer in trans by 
a putative BT22.47 transfer factor. (This putative factor 
may have been the LV22 Trans Factor, the original subject 
of this study. see Description of the Transfer Mechanisms 
of the B. fragilis strain LV22, Chapter 4.) The existence 
of additional transfer factors in BT22.47, however, 
remains to be determined. 
We had thus isolated a 4.2 kb plasmid, pLV22a, from 
B. fragilis LV22 that displayed indirect evidence of 
conjugative transfer in Bacteroides. Our next objective 
was to more exactly determine the nature of pLV22a 
transfer. 
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characterization of the conjugative Transfer Properties of 
pLV22a 
pLV22a was identified as part of the Tra+ fusion 
plasmids pTJ47-1 and pTJ47-3, and we hypothesized that the 
transferability of the fusions was related to the presence 
of pLV22a present in cis. We found that pLV22a was indeed 
transferable, both in Bacteroides and in E.coli. In 
Bacteroides, pLV22a, as part of pTJl0, transferred at a 
frequency of 7.1 X 10-9 from the laboratory reference 
strain B. fragilis TM4000 (table 4). This finding is near 
our limit of detection, and is similar to that of pBFTMl0 
and Tn4399, which both transfer from TM4000 at very low 
frequency (41,42). 
We questioned what effect a Tet Element would have on 
pLV22a transfer in B. fragilis, since Tet Elements 
increase the transfer frequencies of the Bacteroides 
plasmids pBFTMl0 and pBS-51, and the conjugative 
transposon Tn4399 by 1-2.5 orders of magnitude (42,104). 
Tet Elements are Bacteroides-specific, conjugal (i.e., 
self-transferable) factors (70- -200 kb) that exist on the 
chromosome of their host and express tetracycline, and 
sometimes also erythromycin, resistances (4,102). We 
found that pLV22a transfer was increased by 3.5 orders of 
magnitude, to 1.5 X 10-5 , from B. fragilis TM4.23, a Tet 
Element+ isogeneic strain of TM4000 (table 4). 
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Notably, Bacteroides transfer factors such as pBFTMlO 
and Tn4399 are conjugatively transferred in E.coli when 
co-resident with the conjugal IncPB plasmid R751 (i.e., 
they are mobilized) (59,104). pLV22a, as part of the 
original fusion plasmids pTJ47-1 and pTJ47-3, is also 
mobilized from E.coli when co-resident with R751, at 
frequencies similar to pBFTMlO and Tn4399 (table 3). To 
ensure that the parental plasmid of pTJ47-1 and pTJ47-3, 
pGAT400•BglII, is not required for pLV22a mobilization, 
pLV22a was cloned into the Mob- vector pACYC184, giving 
pTJ5a and pTJ6. pTJ5a and pTJ6 were mobilized at 
frequencies equal to or greater than the mobilization 
frequencies of pTJ47-1 and pTJ47-3, thus demonstrating 
that pGAT400•BglII is not required for pLV22a mobilization 
in E.coli (table 3). We also found that pTJ6 was 
mobiltz_e_d _at_a lligher freq_\lE!nc.y tJgi..rr.w~r-~ __ p_'l\J5a, pTJ47-1 
-- . -·~·~-- . "'"·-----.-
and pTJ47-3 (table 3). The reason for this increase in 
mobilization frequency is unknown, but may be related to 
the way in which pTJ5a and pTJ6 were constructed: in 
pTJ5a, pLV22a is inserted into the chloramphenicol 
resistance gene of pACYC184, while pTJ6 contains pLV22a in 
the tetracycline resistance gene of pACYC184 (See Plasmid 
constructions, Chapter 3.) 
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The mechanism by which Bacteroides Tet Elements 
increase the transfer of pLV22a and other co-resident 
Bacteroides transfer factors is unclear, but may be 
related to the way in which these same plasmids are 
mobilized in E. coli when co-resident with R751. In the 
family Enterobacteriaceae, of which E. coli is a member, 
2 major groups of naturally occurring plasmids exist that 
transfer by conjugative mechanisms. The first group, 
typified by RP4, R751, and F, is comprised of large, 
conjugal plasmids (50- >100 kb) that encode virtually all 
of the many functions needed for their own transfer. 
Plasmids of the second group, such as RSF1010 {23) and 
ColEl {10), are smaller than conjugal plasmids {~10 kb), 
do not encode all functions required for transfer, and are 
thus not self-transferable. However, they do encode 2 
components that have been found to be essential for 
conjugative transfer: (g) a cis-acting origin of transfer 
(oriT), the site at which one strand of DNA is nicked in a 
specific manner in preparation for transfer into the 
recipient cell, {10,24), and (b) a limited number of 
trans-acting proteins that recognize, and then nick, their 
cognate oriT {8,10,49). Because plasmids of the second 
group contain these 2 elements, they are able to initiate 
DNA processing at oriT, and are conjugatively mobilized to 
a recipient cell when co-resident with certain conjugal 
plasmids. We and others infer that the conjugal plasmid 
supplies the additional, more generalized transfer 
functions not encoded by the mobilized plasmid (123). 
98 
The 2-step model of Enterobacteriaceae plasmid 
mobilization may serve to explain the increased transfer 
of pLV22a, pBFTMlO and Tn4399 that is observed when they 
are co-resident with a conjugal Tet Element in B. 
fragilis, and also their mobilization in E.coli, when co-
resident with R751. Both pBFTMlO and Tn4399 resemble 
mobilizable plasmids from the Enterobacteriaceae family in 
size (14.6 kb and 9.6 kb, respectively) and in the limited 
number of transfer functions they encode (i.e., an oriT 
and 2 transfer proteins involved in binding and nicking at 
their cognate origins of transfer) (41,59,60) (D.W. Hecht, 
personal communication). pLV22a is also small (4.2 kb), 
and encodes 3 proteins and an oriT required for 
mobilization. It is thus possible that pLV22a, Tn4399 and 
pBFTMlO encode only the functions required for nicking 1 
strand of DNA at their cognate oriT, while the other, more 
generalized transfer functions required to complete 
tr-ans.fer are provided by Tet Elements in Bacteroides and 
by R751 in E.coli. It is important to note that while 
pLV22a, pBFTMlO, and Tn4399 all conjugatively transfer in 
both E.coli and B. fragilis, only pBFTMlO has been shown 
to use the same transfer genes in both species (41). 
The finding that pLV22a was mobilizable in E. coli 
when co-resident with R751 was: fortuitous,, since the use 
, _; 
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of this species allowed us to apply molecular methods not 
available in Bacteroides. Genetic exchange between 
Bacteroides and E.coli may also have a physiologic basis 
since: (a) Bacteroides plasmids can transfer at least as 
efficiently from Bacteroides to E.coli as from 
Bacteroides to Bacteroides (41). (We regularly use E. 
coli as a recipient in conjugative matings from 
Bacteroides.) (b) Plasmids that can transfer in E. coli, 
such as R751, can also transfer to Bacteroides (103). (~) 
Bacteroides and E. coli flourish together in their natural 
habitat, the mammalian gut, and are frequently co-isolated 
from intra-abdominal abscesses {See Epidemiology, Chapter 
2). In spite of these findings, conjugative plasmids 
alone do not appear to be capable of efficiently 
transferring genetic information between Bacteroides and 
Escherichia, since plasmids from 1 genus are not 
maintained in the other genus, and most genes from 1 genus 
are not expressed in the other (35,47,103,105). However, 
transposable elements such as Tn4400 and Tn4351 can 
transpose in both E.coli and Bacteroides {103,105), 
acquire new DNA by inverse transposition (81, this study), 
and have promoters that can drive expression of newly-
acquired genes in both genera (79). Conjugative plasmids 
could thus act together with transposable elements to 
successfully exchange genetic information between 
Bacteroides and Escherichia. In this model of inter-genus 
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genetic exchange, the transposon would acquire, express 
and mobilize genes within the cell, while the conjugative 
plasmid would serve as an intercellular carrier of a 
transposon and its genetic information. 
Localization and DNA seguence Analysis of the pLv22a 
Mobilization Region 
After determining that pLV22a possessed a conjugative 
mobilization region, we created a library of pLV22a 
insertion mutants with Tn1000. By screening the library 
for mutants that were no longer mobilizable in E.coli, 
and then mapping the positions of Tn1000 in those mutants, 
we identified a 1.5 kb region required for mobilization. 
We then used these same Mob- mutants, together with 
outward-facing primers to both ends of TnlOOO, to 
determine the nucleic acid sequence of the pLV22a 
mobilization region (fig. 12). 
While mapping mutant positions in pLV22a, a 1.0 kb 
region of pLV22a was identified that was resistant to 
Tn1000 insertion (fig. 11). This region is not required 
for mobilization in E.coli, since it is not present in 
the fully mobilizable plasmid pTJ6XB (table 3}; however, 
the region could be involved in pLV22a transfer in 
Bacteroides. Computerized DNA sequence analysis (DNASIS, 
Version 3.00 for IBM compatible computers, Hitachi 
Software Corp.) of the 1.5 kb pLV22a mobilization region 
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identified 3 ORFs of greater than 10 kDa size in the "top" 
strand, orf 1, orf 2 and orf 3, and 2 major ORFs, orf 4 
and orf 5, in the "bottom" strand. TnlOOO insertions into 
orf 1, orf 2 and orf 3 resulted in Mob- phenotypes, 
implying that all 3 are required for mobilization in E. 
coli (fig. 13). Due to the nested architecture of orf 4 
and orf 5 within orf 2, no conclusions could be drawn from 
Tn1000 mutagenesis data concerning the necessity of orf 4 
and orf 5 for mobilization (fig. 13). orf 1 and orf 2 
overlap by 4 bp, orf 2 and orf 3 overlap by 44 bp, and orf 
5 overlaps orf 4 by 326 bp (fig. 12 and fig. 13). The 
derived protein products of orf 1, orf 2, orf 3, orf 4, 
and orf 5 are 11.7 kDa, 29.4 kDa, 17.6 kDa, 18.9 kDa and 
13.4 kDa in size, respectively, based upon the first 
methionine codon in each ORF (fig. 12). While relatively 
small, these derived protein sizes are similar to the DNA 
processing proteins of: Tn4399, MocA (36.4 kDa) and MocB 
(16.4 kDa); pBFTMl0, BtgA (23.2 kDa) and BtgB (33.8 kDa); 
ColEl, MbeB (17 kDa), MbeC (12 kDa) and MbeD (9 kDa) 
(10,41,59). 
We had now experimentally identified the 1.5 kb 
region of pLV22a required for mobilization, sequenced this 
region, and identified 5 major ORF's. Our next 
experiments were designed to test whether orf 1, orf 2, 
and orf 3 are required for pLV22a mobilization in E. coli 
when co-resident with R751. 
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Identification and Characterization of the pLv22a Genes 
Reguired for Mobilization in E, coli 
We used complementation analysis to confirm that orf 
1, orf 2 and orf 3 produce trans-acting products that are 
required for mobilization. Because orf 4 and orf 5 are 
located entirely within orf 2, complementation analysis 
could not be used to ascertain their role in mobilization 
(fig 13). We established that mutations in the 
mobilization region clearly fell into 1 of 3 
complementation groups: mutations in orf 1; mutations in 
orf 2; and mutations in orf 3 (table 6). That each 
complementation group contains mutations in only 1 major 
top strand ORF (i.e., orf 1, orf 2 or orf 3), and that no 
instances of Tnl000-induced polarity on downstream ORF's 
were seen, strongly argues that each ORF is an 
independently promoted gene whose trans-acting product is 
required for mobilization. Based on these data, we 
renamed orf 1, orf 2 and orf 3 mbpA, mbpB, and mbpC, 
respectively. 
Promoter and ribosomal binding site consensus 
sequences have not as yet been identified in Bacteroides. 
However, since pLV22a is mobilized in E.coli, we analyzed 
mbpA, mbpB, mbpC, orf 4, and orf 5 for the presence of the 
major, E. coli cr70 promoter, and for Shine-Dalgarno 
ribosomal binding sites. No strong homology to either the 
-10/-35 promoter or Shine-Dalgarno consensus sequences was 
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observed. If the expression of mbpA, mbpB, and mbpC is 
necessary for transfer in Bacteroides as well as in E. 
coli, their promoters and ribosomal binding sites may 
contain customized sequences that are recognized in both 
E.coli and in Bacteroides; this could account for our 
inability to identify E.coli transcription/translation 
signals in mbpA, mbpB, and mbpC, as well as in orf 4 and 
orf 5. 
DNA sequence analysis detected 2 additional 
characteristics of pTJ47-1 and pTJ47-3, the original 
pLV22a fusion plasmids, that were a result of 
pGAT400•BglII insertion into pLV22a at 2 different sites. 
In pTJ47-1, the mbpA coding region begins only 19 bp 
distal from IS4400 1eft of pGAT400•BglII (figs. 12, 13). 
Thus, the mbpA promoter would appear to be interrupted in 
this clone. We speculate that mbpA may be promoted by an 
outward facing promoter potentially present in IS4400 left. 
(IS4400 is not known to have such promoters. However, 
outward facing promoters active in E.coli have been 
identified in a closely related insertion element, IS4351 
(79).) In pTJ47-3, mbpA contains its native upstream 
sequence, and is thus probably promoted by its own 
promoter. The fact that no significant difference was 
noted in the mobilization frequencies of pTJ47-1 and 
pTJ47-3 (table 3) could indicate that the mbpA native 
promoter is of similar strength to the putative IS4400 
promoter, that MbpA is not a limiting factor in plasmid 
mobilization efficiency, or both. 
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Sequence analysis also discovered that pTJ47-3 
contains an interruption of mbpC 7 nucleotides upstream of 
its translational stop codon (fig. 12). The amino acids 
encoded by these codons do not however appear to be 
necessary for mobilization, since pTJ47-3 is fully 
mobilizable respective to pTJ47-1, in which mbpC is 
intact. 
Several lines of evidence suggest that MbpB is the 
DNA relaxing enzyme, or relaxase, of pLV22a. (Relaxases 
are those enzymes that specifically nick 1 strand of DNA 
at a cognate oriT sequence in preparation for conjugative 
transfer. For more on relaxases, see Horizontal Gene 
Transfer Factors, Chapter 2.) The BestFit program of the 
Genetics Computer Group package {Version 8.0) was used to 
compare MbpB with the transfer proteins of pBFTMl0 and 
Tn4399. BestFit, which makes an optimal alignment of the 
best segment of similarity between two sequences, 
identified a 73 aa segment of MocA, a proposed relaxase of 
the B. fragilis conjugative transposon Tn4399, that is 38% 
identical to a region of MbpB (fig. 14) (59). We also 
identified a 6/10 match (8/10 when conservative 
substitutions are included) between MbpB and a consensus 
sequence that was derived from confirmed and putative 
bacterial relaxases (68) (fig. 14). Both MbpB and MocA 
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A. 
MbpB (pLV22a) 
MocA (Tn4399) 
MobA (pC221) 
TraI (RP4) 
TraI (R751) 
VirD2 (pTIA6) 
VirD2 (pRIA4) 
NikB (R64) 
105 RH SGT 
97 YI VAR 
94 VA VY T 
104 RVS AV 
104 RISA V 
126 Y LT A Y 
126 Y LT AF 
153 Y VS AV 
E 
H 
H 
H 
H 
H 
H 
H 
s K K ~~ 
T D R E H 
T D K D H 
N D T D N 
N D T D N 
V D R D H 
I D R D H 
T D T D N 
A !! L 
p H C 
y H N 
L H I 
L H I 
p H L 
p H L 
L H V 
!! J ~ ~ I;l; 
H I V F N 
H I V I N 
H I A I N 
H I A I N 
H V vv N 
H V V V N 
H V A V N 
R V S F 
R V D N 
S V D L 
K I H P 
K I H P 
R R E L 
R R E L 
R V H P 
Consensus: H 
B. 
MbpB 59 V k n n C L r F e V S p s 
MocA 57 V g h t s L n F - - s P e 
MbpB 88 n D f M q r M G l a N h Q 
MocA 84 h D y M a k M G i e N t Q 
MbpB 117 H l H I l a ~I~ V s f ~ G MocA 109 H c H I V f V d n G 
D 
i e 
d g 
y I 
y I 
n C 
k t 
D N 
H 
E s 
E r 
i i 
V a 
t g 
i s 
H 
a t 
l k 
~I~ 
t t 
d k 
H c C C N 
f t D A d w a e l 
t d D A l m l q i 
s ~ t e s k k E ~ t - - r E 
m D 
n D 
Fig. 14. Boxed sequences denotes conserved relaxase regions 
according to Pansegrau and Lanka (see text for details). The number 
to the left of each sequence denotes the position of the first 
illustrated amino acid. A.... Alignment of putative relaxase regions 
of MbpB (pLV22a) with other putative and known relaxase sequences. 
The letter~ in the consensus sequence denotes neutral, hydrophobic, 
amino acids. Underlined letters in the MbpB sequence denote amino 
acids identical to the consensus sequence, or amino acids which 
represent conserved substitutions • .a.,_ Alignment of amino acid 
sequences from MbpB and MocA (Tn4399), overlapping the putative 
relaxase region as illustrated in Part A. Uppercase letters denote 
identical amino acid residues, while lowercase letters denote 
different residues. 
g 
a 
a 
p 
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carry the relaxase consensus sequence within their regions 
that also display 38% identity (fig. 14). While 
imperfect, we consider the match between MbpB and the 
consensus sequence to be significant, since Bacteroidaceae 
are distantly related to the bacteria from which the 
consensus is derived (122). Notably, MbpB contains 
conserved histidine residues in the consensus sequence at 
positions 117 and 119. These histidine residues are also 
present in the consensus sequence of a known relaxase, 
TraI of RP4 (aa 116 and 118), and are critical for nicking 
at oriTRP4 (fig. 14) (70). The homology between MocA and 
MbpB around the relaxase consensus sequence suggests that 
these proteins, from otherwise very different transfer 
factors, may share a common ancestral gene. In contrast, 
BestFit did not identify significant homology between MbpB 
and the transfer proteins of the B. fragilis plasmid 
pBFTMl0, BtgA and BtgB, making a common predecessor for 
these proteins less likely. 
We also used FastA and TFastA of the Genetics 
Computer Group package to compare mbpA, mbpB, mbpC, orf 4 
and orf 5 to sequences in the GenBank/EMBL database. Both 
FastA and TFastA perform Pearson and Lipman searches for 
similarity between a query sequence and a group of 
database sequences. FastA analyzes both strands of a DNA 
sequence, while TFastA analyzes all 6 open reading frames 
derived from a DNA sequence. No significant homologies 
between pLV22a and databank sequences were identified. 
studies are currently under way to investigate whether 
MbpB is indeed a relaxase that is active in nicking at 
oriTpL~2a, and to discover what roles MbpA and MbpC may 
play in the process. 
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cloning a cis-acting Region Required for Mobilization 
Complementation analysis of mbpA determined that 
TnlOOO insertion mutation 67, which is located within mbpA 
at nt 317, was only partially complemented when MbpA was 
provided in trans (see table 6, Mobilization genotype 
mbJ;lA, mobilization of pAC67 by complementing plasmids 
pBR39 and pBR18). This suggested to us that the 
relatively large transposon insertion of mutation 67 was 
disrupting both mbpA and the cis-acting oriTpL~2a. Using 
computer analysis, we also identified 2 imperfect inverted 
repeats within mbpA, the first spanning from nt 234 - nt 
260, the other from nt 267 - nt 292 (fig. 12). The 
finding of inverted repeats near mutation 67 supported the 
idea that the pLV22a oriT is located within mbpA, since 
inverted repeats have been previously identified in other 
bacterial origins of transfer (41,60,126). To test this 
hypothesis, we PCR-amplified a 347 bp region (nt 44 to nt 
390) around mutation 67, and cloned the fragment into the 
Mob- vector pACYC184 (fig. 12). We found that this 
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construct, pTJ347, was fully mobilizable from E. coli when 
co-resident with R751 and wild-type pLV22a on a compatible 
plasmid (table 7). This result indicated that the 347 bp 
PCR fragment, from within mbpA, contains the pLV22a oriT. 
DNA sequence analysis of the fragment identified a region 
that displays 66.7% homology to the 12 bp oriT/nick-site 
consensus sequence of Pansegrau and Lanka (68): 
pLV22a 
Consensus: 
G T A C 
G T 
T C 
Bacteroidaceae are distantly related to the bacteria from 
which this consensus is derived (122), and we therefore 
consider the match, while imperfect, to nevertheless be 
significant. We have thus localized the pLV22a oriT to a 
347 bp region that is located primarily within mbpA. This 
is not unique: the Tn4399 oriT also resides in a 
mobilization gene, mocB {59). Experiments to identify the 
nick site within the 347 bp PCR fragment, using PCR cycle-
sequencing, are currently under way. 
Potential Functions of the pLV22a Mobilization Proteins 
While the genes required for pLV22a mobilization in 
E. coli are known, the functions of their protein 
products, MbpA, MbpB and Mbpc, are not. We propose that 
MbpA, MbpB and MbpC function to recognize and bind at 
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oriTPL~2a, and to then specifically nick 1 strand of DNA in 
preparation for transfer. This model, which is based upon 
the relatively well characterized DNA processing systems 
of conjugative plasmids found in bacteria of the family 
Enterobacteriaceae, may also apply to Bacteroides transfer 
factors other than pLV22a. (For a review of Bacteroides 
factors, see Chapter 2, Horizontal Transfer Factors.) 
Among the Enterobacteriaceae, 3 plasmids whose DNA 
processing mechanisms have been extensively reported on 
are ColEl, RSFl0l0, and RP4. 
The 6.6 kb plasmid ColEl encodes 4 proteins, MbeA (60 
kDa), MbeB (17 kDa), MbeC (12 kDa) and MbeD (9 kDa), which 
are required for mobilization when co-resident with IncF, 
Incl, IncP or IncW conjugal plasmids (10). Helinski et 
al. have determined that three mobilization proteins 
(probably MbeA, MbeB and MbeC), form a relaxosome at the 
ColEl oriT. A 60 kDa relaxosome protein that is likely 
MbeA becomes covalently linked to the 5' end of the nicked 
DNA strand, and may act to chaperon this strand into the 
recipient while protecting it from 5 1 exonucleases. The 
60 kDa protein may also re-circularize the strand in the 
recipient (8,36,49). 
RSF1010 is an 8.9 kb IncQ plasmid that is mobilized 
when co-resident with conjugal plasmids of the Incia, 
IncM, IncP and IncX groups. RSFl0l0 encodes 3 relaxosome 
proteins, MobA, MobB and MobC, that are required for 
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mobilization in vivo (23). MobA is a large (78 kDa), 
multi-functional protein that recognizes a specific 
sequence in oriTRsnoio, binds to the sequence, and then 
nicks 1 strand of DNA within the oriT. After nicking, 
MobA covalently bonds to the 5' end of the broken DNA 
strand, where it may act to recircularize the strand 
following entry of the nucleoprotein complex into the 
recipient (94,95). (MobA is unusual in that it is also 
known as RepB, and functions as a primase in the 
vegetative replication of RSFl0l0 (96).) The second 
relaxosome protein, MobB, increases the efficiency of in 
vitro nicking at oriT by either stabilizing the relaxosome 
complex, or by altering the local DNA topology (95). The 
third protein, Mobc, is a helicase that is brought into 
the relaxosome by MobA, and may serve to melt the double-
stranded DNA molecule prior to nicking (95). 
While all the details of DNA processing in ColEl and 
RSFl0l0 have not been elucidated, it is clear that each 
encodes several proteins that function in the context of a 
relaxosome to specifically nick 1 strand of DNA at a site 
within their cognate oriT. Perhaps the most well studied 
DNA processing system is that of the IncP plasmid RP4. 
RP4 is very different from ColEl and RSFl0l0, and also 
pLV22a, in that it is much larger (60 kb), and is fully 
self-transferable. However, one way in which RP4 
resembles ColEl and RSF1010 is that it too uses a 
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relaxosome to specifically nick 1 strand of DNA at its 
oriT prior to transfer. In RP4 relaxosome formation, TraJ 
first recognizes, and then binds, to the right half of a 
19 bp inverted repeat sequence within the oriT (126). 
TraI then recognizes a 6 bp sequence between the nick site 
of oriT and the TraJ-binding site, and joins the TraJ-oriT 
nucleoprotein complex (69). TraH specifically interacts 
with both TraI and TraJ, and is proposed to stabilize the 
relaxosome (67), while TraK acts to enhance nicking at 
oriT by locally altering the DNA superhelicity (29,127). 
Once the relaxosome is formed, TraI cleaves a defined 
strand of DNA at the nick site, after which TraI becomes 
covalently attached to the 5' phosphoryl end (69). 
MbpA, MbpB and MbpC may also function in a relaxosome 
to nick 1 strand of DNA within oriTpL~2a• As discussed 
above, MbpB appears to be the relaxase of pLV22a. As the 
relaxase, MbpB may both recognize and bind to a site 
within oriTpL~2a, and then nick 1 strand of DNA. This is 
similar to MobA of RSFlOlO, the relaxase which both 
recognizes and binds to oriTRsnow, and then provides the 
nicking function. Alternatively, MbpB may require MbpA 
and/or MbpC to first recognize and bind oriTpL~2 a before it 
can enter the relaxosome/DNA complex (as is seen with 
TraJ/TraI of RP4) (fig. 15). 
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MbpA/MbpC 
MbpB 
. 
IC 
/ t_ 
---►- --◄---- ---►- ... ◄----
IR 1 IR 2 
mbpA 
Fig. 15. Model of potential nucleoprotein interactions at the oriT 
of pLV22a. IR 1 and IR 2 represent inverted repeats 1 and 2, as 
found in figure 12. Dotted arrow represents potential covalent 
bonding of an Mbp protein to the nicked strand of DNA at its 5' end. 
Dashed horizontal lines represent double-stranded DNA. The position 
of nic in this figure is hypothetical. 
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MbpA, MbpB and MbpC may also: 
(g) possess helicase activity, which would serve to 
melt the DNA prior to nicking, as does MobC in the 
RSF1010 system; 
(b) act to stabilize the relaxosome complex, as is 
seen with TraH of RP4; 
(~) alter the local DNA topography to facilitate 
oriT recognition and binding by the relaxosome, as 
does TraK of RP4; 
(d) covalently bond to the nicked strand of pLV22a 
and then act to chaperon the strand into the 
recipient. Once in the recipient, the bound protein 
may act to protect the strand from nuclease attack, 
and participate in re-circularizing the DNA strand 
prior to second-strand synthesis. (Some of these 
functions are thought to be fulfilled by MobA of 
RSF1010 and MbeA of ColEl.) As chaperon, the bound 
pLV22a protein may also interact with transfer 
proteins from the conjugal plasmid that assist in 
transfer and re-circularization of the nicked strand, 
and with bacterial proteins to assist in second 
strand synthesis. 
Experiments are currently being conducted in our 
laboratory to test this model. 
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